\begin{thebibliography}{205}
\providecommand{\natexlab}[1]{#1}
\providecommand{\urlprefix}{}
\providecommand{\doiprefix}{doi: }

\bibitem[{Siegel et~al.(2018)Siegel, Rebecca L and Miller, Kimberly D and
  Jemal, Ahmedin}]{Siegel:2018cq}
\textbf{\color{eLifeMediumGrey} Siegel RL}, Miller KD, Jemal A.
\newblock {Cancer statistics, 2018.}
\newblock CA: a cancer journal for clinicians.  2018 Jan; 68(1):7--30.

\bibitem[{Cohen and Tcherpakov(2010{\natexlab{a}})Cohen, Philip and Tcherpakov,
  Marianna}]{Cohen:2010fs}
\textbf{\color{eLifeMediumGrey} Cohen P}, Tcherpakov M.
\newblock {Will the ubiquitin system furnish as many drug targets as protein
  kinases?}
\newblock Cell.  2010 Nov; 143(5):686--693.

\bibitem[{{Robert Roskoski Jr}(2017)}]{fda-approved-kinase-inhibitors}
\textbf{\color{eLifeMediumGrey} {Robert Roskoski Jr}}.
\newblock {{USFDA}} Approved Protein Kinase Inhibitors.
\newblock .  2017; \urlprefix\url{http://www.brimr.org/PKI/PKIs.htm}, updated 3
  May 2017.

\bibitem[{{Paul, Steven M} et~al.(2010){Paul, Steven M} and {Mytelka, Daniel S}
  and {Dunwiddie, Christopher T} and {Persinger, Charles C} and {Munos, Bernard
  H} and {Lindborg, Stacy R} and {Schacht, Aaron L}}]{Paul:2010ff}
\textbf{\color{eLifeMediumGrey} {Paul, Steven M}}, {Mytelka, Daniel S},
  {Dunwiddie, Christopher T}, {Persinger, Charles C}, {Munos, Bernard H},
  {Lindborg, Stacy R}, {Schacht, Aaron L}.
\newblock {How to improve R{\&}D productivity: the pharmaceutical industry's
  grand challenge.}
\newblock Nature reviews Drug discovery.  2010 Mar; 9(3):203--214.

\bibitem[{Sanchez-Vega et~al.(2018)Sanchez-Vega, Francisco and Hechtman, Jaclyn
  F and Castel, Pau and Ku, Geoffrey Y and Tuvy, Yaelle and Won, Helen and
  Fong, Christoper J and Bouvier, Nancy and Nanjangud, Gouri J and Soong,
  Joanne and Vakiani, Efsevia and Schattner, Mark and Kelsen, David P and
  Lefkowitz, Robert A and Brown, Karen and Lacouture, Mario E and Capanu,
  Marinela and Mattar, Marissa and Qeriqi, Besnik and Cecchi, Fabiola and Tian,
  Yuan and Hembrough, Todd and Nagy, Rebecca J and Lanman, Richard B and
  Larson, Steven M and Pandit-Taskar, Neeta and Schoder, Heiko and
  Iacobuzio-Donahue, Christine A and Ilson, David H and Weber, Wolfgang A and
  Berger, Michael F and de Stanchina, Elisa and Taylor, Barry S and Lewis,
  Jason S and Solit, David B and Carrasquillo, Jorge A and Scaltriti, Maurizio
  and Schultz, Nikolaus and Janjigian, Yelena Y}]{SanchezVega:2018jg}
\textbf{\color{eLifeMediumGrey} Sanchez-Vega F}, Hechtman JF, Castel P, Ku GY,
  Tuvy Y, Won H, Fong CJ, Bouvier N, Nanjangud GJ, Soong J, Vakiani E,
  Schattner M, Kelsen DP, Lefkowitz RA, Brown K, Lacouture ME, Capanu M, Mattar
  M, Qeriqi B, Cecchi F, et~al.
\newblock {EGFR and MET Amplifications Determine Response to HER2 Inhibition in
  ERBB2-Amplified Esophagogastric Cancer.}
\newblock Cancer discovery.  2018 Nov; .

\bibitem[{Pao et~al.(2005)Pao, William and Miller, Vincent A and Politi,
  Katerina A and Riely, Gregory J and Somwar, Romel and Zakowski, Maureen F nd
  Kris, Mark G and Varmus, Harold}]{Pao:2005dp}
\textbf{\color{eLifeMediumGrey} Pao W}, Miller VA, Politi KA, Riely GJ, Somwar
  R, Zakowski MG Maureen F nd~Kris, Varmus H.
\newblock {Acquired resistance of lung adenocarcinomas to gefitinib or
  erlotinib is associated with a second mutation in the EGFR kinase domain.}
\newblock PLoS medicine.  2005 Mar; 2(3):e73.

\bibitem[{Knight et~al.(2010{\natexlab{a}})Knight, Zachary A. and Lin, Henry
  and Shokat, Kevan M.}]{Knight:Nat.Rev.Cancer:2010}
\textbf{\color{eLifeMediumGrey} Knight ZA}, Lin H, Shokat KM.
\newblock Targeting the Cancer Kinome through Polypharmacology.
\newblock Nat Rev Cancer.  2010; 10(2):130.

\bibitem[{Chandarlapaty et~al.(2011{\natexlab{a}})Chandarlapaty, Sarat and
  Sawai, Ayana and Scaltriti, Maurizio and Rodrik-Outmezguine, Vanessa and
  Grbovic-Huezo, Olivera and Serra, Violeta and Majumder, Pradip K. and
  Baselga, Jose and Rosen, Neal}]{Chandarlapaty:CancerCell:2011}
\textbf{\color{eLifeMediumGrey} Chandarlapaty S}, Sawai A, Scaltriti M,
  Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V, Majumder PK, Baselga J, Rosen
  N.
\newblock {{AKT Inhibition Relieves Feedback Suppression}} of {{Receptor
  Tyrosine Kinase Expression}} and {{Activity}}.
\newblock Cancer Cell.  2011 Jan; 19(1):58--71.
\newblock \href{10.1016/j.ccr.2010.10.031}{\doiprefix
  \detokenize{10.1016/j.ccr.2010.10.031}}.

\bibitem[{Rudmann(2013)Rudmann, Daniel G}]{Rudmann2013-hi}
\textbf{\color{eLifeMediumGrey} Rudmann DG}.
\newblock On-target and off-target-based toxicologic effects.
\newblock Toxicol Pathol.  2013 Feb; 41(2):310--314.

\bibitem[{Liu and Kurzrock(2014)Liu, Sariah and Kurzrock, Razelle}]{Liu2014-yi}
\textbf{\color{eLifeMediumGrey} Liu S}, Kurzrock R.
\newblock Toxicity of targeted therapy: Implications for response and impact of
  genetic polymorphisms.
\newblock Cancer Treat Rev.  2014 Aug; 40(7):883--891.

\bibitem[{Manning et~al.(2002{\natexlab{a}})Manning, G and Whyte, D B and
  Martinez, R and Hunter, T and Sudarsanam, S}]{Manning2002-cw}
\textbf{\color{eLifeMediumGrey} Manning G}, Whyte DB, Martinez R, Hunter T,
  Sudarsanam S.
\newblock The Protein Kinase Complement of the Human Genome.
\newblock Science.  2002 Dec; 298(5600):1912--1934.

\bibitem[{Cowan-Jacob et~al.(2007)Cowan-Jacob, S W and Fendrich, G and
  Floersheimer, A and Furet, P and Liebetanz, J and Rummel, G and Rheinberger,
  P and Centeleghe, M and Fabbro, D and Manley, P W and
  {IUCr}}]{Cowan-Jacob2007-rn}
\textbf{\color{eLifeMediumGrey} Cowan-Jacob SW}, Fendrich G, Floersheimer A,
  Furet P, Liebetanz J, Rummel G, Rheinberger P, Centeleghe M, Fabbro D, Manley
  PW, {IUCr}.
\newblock Structural biology contributions to the discovery of drugs to treat
  chronic myelogenous leukaemia.
\newblock Acta Crystallogr D Biol Crystallogr.  2007 Jan; 63(1):80--93.

\bibitem[{Seeliger et~al.(2007)Seeliger, Markus A and Nagar, Bhushan and Frank,
  Filipp and Cao, Xiaoxian and Henderson, M Nidanie and Kuriyan,
  John}]{Seeliger2007-jn}
\textbf{\color{eLifeMediumGrey} Seeliger MA}, Nagar B, Frank F, Cao X,
  Henderson MN, Kuriyan J.
\newblock c-Src Binds to the Cancer Drug Imatinib with an Inactive {Abl/c-Kit}
  Conformation and a Distributed Thermodynamic Penalty.
\newblock Structure.  2007 Mar; 15(3):299--311.

\bibitem[{Huse and Kuriyan(2002)Huse, M and Kuriyan, J}]{Huse2002-ml}
\textbf{\color{eLifeMediumGrey} Huse M}, Kuriyan J.
\newblock The conformational plasticity of protein kinases.
\newblock Cell.  2002 Jan; 109(3):275--282.

\bibitem[{Harrison(2003)Harrison, Stephen C}]{Harrison2003-ct}
\textbf{\color{eLifeMediumGrey} Harrison SC}.
\newblock Variation on an Src-like theme.
\newblock Cell.  2003 Mar; 112(6):737--740.

\bibitem[{Nagar et~al.(2003)Nagar, Bhushan and Hantschel, Oliver and Young,
  Matthew A and Scheffzek, Klaus and Veach, Darren and Bornmann, William and
  Clarkson, Bayard and Superti-Furga, Giulio and Kuriyan, John}]{Nagar:2003tu}
\textbf{\color{eLifeMediumGrey} Nagar B}, Hantschel O, Young MA, Scheffzek K,
  Veach D, Bornmann W, Clarkson B, Superti-Furga G, Kuriyan J.
\newblock {Structural basis for the autoinhibition of c-Abl tyrosine kinase.}
\newblock Cell.  2003 Mar; 112(6):859--871.

\bibitem[{Davis et~al.(2011{\natexlab{a}})Davis, Mindy I and Hunt, Jeremy P and
  Herrgard, Sanna and Ciceri, Pietro and Wodicka, Lisa M and Pallares, Gabriel
  and Hocker, Michael and Treiber, Daniel K and Zarrinkar, Patrick
  P}]{Davis:Nat.Biotechnol.:2011}
\textbf{\color{eLifeMediumGrey} Davis MI}, Hunt JP, Herrgard S, Ciceri P,
  Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP.
\newblock Comprehensive Analysis of Kinase Inhibitor Selectivity.
\newblock Nat Biotechnol.  2011 Oct; 29(11):1046--1051.
\newblock \href{10.1038/nbt.1990}{\doiprefix \detokenize{10.1038/nbt.1990}}.

\bibitem[{Apsel et~al.(2008)Apsel, Beth and Blair, Jimmy A and Gonzalez,
  Beatriz and Nazif, Tamim M and Feldman, Morri E and Aizenstein, Brian and
  Hoffman, Randy and Williams, Roger L and Shokat, Kevan M and Knight, Zachary
  A}]{Apsel2008-it}
\textbf{\color{eLifeMediumGrey} Apsel B}, Blair JA, Gonzalez B, Nazif TM,
  Feldman ME, Aizenstein B, Hoffman R, Williams RL, Shokat KM, Knight ZA.
\newblock Targeted polypharmacology: discovery of dual inhibitors of tyrosine
  and phosphoinositide kinases.
\newblock Nat Chem Biol.  2008 Nov; 4(11):691--699.

\bibitem[{Hopkins et~al.(2006)Hopkins, Andrew L and Mason, Jonathan S and
  Overington, John P}]{Hopkins2006-qu}
\textbf{\color{eLifeMediumGrey} Hopkins AL}, Mason JS, Overington JP.
\newblock Can we rationally design promiscuous drugs?
\newblock Curr Opin Struct Biol.  2006 Feb; 16(1):127--136.

\bibitem[{Hopkins(2008)Hopkins, Andrew L}]{Hopkins2008-ij}
\textbf{\color{eLifeMediumGrey} Hopkins AL}.
\newblock Network pharmacology: the next paradigm in drug discovery.
\newblock Nat Chem Biol.  2008 Nov; 4(11):682--690.

\bibitem[{Zhang et~al.(2009)Zhang, Jianming and Yang, Priscilla L and Gray,
  Nathanael S}]{Zhang2009-il}
\textbf{\color{eLifeMediumGrey} Zhang J}, Yang PL, Gray NS.
\newblock Targeting cancer with small molecule kinase inhibitors.
\newblock Nat Rev Cancer.  2009 Jan; 9(1):28--39.

\bibitem[{Huggins et~al.(2012)Huggins, David J and Sherman, Woody and Tidor,
  Bruce}]{Huggins2012-hr}
\textbf{\color{eLifeMediumGrey} Huggins DJ}, Sherman W, Tidor B.
\newblock Rational approaches to improving selectivity in drug design.
\newblock J Med Chem.  2012 Feb; 55(4):1424--1444.

\bibitem[{Mendoza et~al.(2011)Mendoza, Michelle C and Er, E Emrah and Blenis,
  John}]{Mendoza2011-bj}
\textbf{\color{eLifeMediumGrey} Mendoza MC}, Er EE, Blenis J.
\newblock The {Ras-ERK} and {PI3K-mTOR} pathways: cross-talk and compensation.
\newblock Trends Biochem Sci.  2011 Jun; 36(6):320--328.

\bibitem[{Tricker et~al.(2015)Tricker, Erin M and Xu, Chunxiao and Uddin,
  Sharmeen and Capelletti, Marzia and Ercan, Dalia and Ogino, Atsuko and
  Pratilas, Christine A and Rosen, Neal and Gray, Nathanael S and Wong,
  Kwok-Kin and J{\"a}nne, Pasi A}]{Tricker2015-xx}
\textbf{\color{eLifeMediumGrey} Tricker EM}, Xu C, Uddin S, Capelletti M, Ercan
  D, Ogino A, Pratilas CA, Rosen N, Gray NS, Wong KK, J{\"a}nne PA.
\newblock Combined {EGFR/MEK} Inhibition Prevents the Emergence of Resistance
  in {EGFR-Mutant} Lung Cancer.
\newblock Cancer Discov.  2015 Sep; 5(9):960--971.

\bibitem[{Chandarlapaty et~al.(2011{\natexlab{b}})Chandarlapaty, Sarat and
  Sawai, Ayana and Scaltriti, Maurizio and Rodrik-Outmezguine, Vanessa and
  Grbovic-Huezo, Olivera and Serra, Violeta and Majumder, Pradip K and Baselga,
  Jos{\'e} and Rosen, Neal}]{Chandarlapaty2011-cq}
\textbf{\color{eLifeMediumGrey} Chandarlapaty S}, Sawai A, Scaltriti M,
  Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V, Majumder PK, Baselga J, Rosen
  N.
\newblock {AKT} Inhibition Relieves Feedback Suppression of Receptor Tyrosine
  Kinase Expression and Activity.
\newblock Cancer Cell.  2011 Jan; 19(1):58--71.

\bibitem[{Bailey et~al.(2014)Bailey, Sean T and Zhou, Bing and Damrauer,
  Jeffrey S and Krishnan, Bhavani and Wilson, Harper L and Smith, Aleisha M and
  Li, Mingqing and Yeh, Jen Jen and Kim, William Y}]{Bailey2014-pd}
\textbf{\color{eLifeMediumGrey} Bailey ST}, Zhou B, Damrauer JS, Krishnan B,
  Wilson HL, Smith AM, Li M, Yeh JJ, Kim WY.
\newblock {mTOR} Inhibition Induces Compensatory, Therapeutically Targetable
  {MEK} Activation in Renal Cell Carcinoma.
\newblock PLoS One.  2014 Sep; 9(9):e104413.

\bibitem[{Littlefield et~al.(2014)Littlefield, Peter and Moasser, Mark~M. and
  Jura, Natalia}]{Littlefield:Chem.Biol.:2014}
\textbf{\color{eLifeMediumGrey} Littlefield P}, Moasser MM, Jura N.
\newblock {{RETRACTED}}: {{An ATP}}-{{Competitive Inhibitor Modulates}} the
  {{Allosteric Function}} of the {{HER3 Pseudokinase}}.
\newblock Chem Biol.  2014 Apr; 21(4):453--458.
\newblock \href{10.1016/j.chembiol.2014.02.011}{\doiprefix
  \detokenize{10.1016/j.chembiol.2014.02.011}}.

\bibitem[{{Yun, Cai-Hong} et~al.(2007){Yun, Cai-Hong} and {Boggon, Titus J} and
  {Li, Yiqun} and {Woo, Michele S} and {Greulich, Heidi} and {Meyerson,
  Matthew} and {Eck, Michael J}}]{Yun:2007jz}
\textbf{\color{eLifeMediumGrey} {Yun, Cai-Hong}}, {Boggon, Titus J}, {Li,
  Yiqun}, {Woo, Michele S}, {Greulich, Heidi}, {Meyerson, Matthew}, {Eck,
  Michael J}.
\newblock {Structures of lung cancer-derived EGFR mutants and inhibitor
  complexes: mechanism of activation and insights into differential inhibitor
  sensitivity.}
\newblock Cancer Cell.  2007 Mar; 11(3):217--227.

\bibitem[{Gajiwala et~al.(2013)Gajiwala, Ketan S and Feng, Junli and Ferre,
  RoseAnn and Ryan, Kevin and Brodsky, Oleg and Weinrich, Scott and Kath, John
  C and Al Stewart}]{Gajiwala:2013bn}
\textbf{\color{eLifeMediumGrey} Gajiwala KS}, Feng J, Ferre R, Ryan K, Brodsky
  O, Weinrich S, Kath JC, Stewart A.
\newblock {Insights into the Aberrant Activity of Mutant EGFR Kinase Domain and
  Drug Recognition}.
\newblock Structure.  2013; 21(2):209--219.

\bibitem[{Song et~al.(2015)Song, Zilan and Wang, Meining and Zhang,
  Ao}]{Song:2015gu}
\textbf{\color{eLifeMediumGrey} Song Z}, Wang M, Zhang A.
\newblock {Alectinib: a novel second generation anaplastic lymphoma kinase
  (ALK) inhibitor for overcoming clinically-acquired resistance}.
\newblock Acta Pharmaceutica Sinica B.  2015 Jan; 5(1):34--37.

\bibitem[{Chodera et~al.(2011{\natexlab{a}})Chodera, John D and Mobley, David L
  and Shirts, Michael R and Dixon, Richard W and Branson, Kim and Pande, Vijay
  S}]{Chodera2011-jn}
\textbf{\color{eLifeMediumGrey} Chodera JD}, Mobley DL, Shirts MR, Dixon RW,
  Branson K, Pande VS.
\newblock Alchemical free energy methods for drug discovery: progress and
  challenges.
\newblock Curr Opin Struct Biol.  2011 Apr; 21(2):150--160.

\bibitem[{Huang and MacKerell(2013)Huang, Jing and MacKerell, Alexander
  D.}]{Huang:J.Comput.Chem.:2013}
\textbf{\color{eLifeMediumGrey} Huang J}, MacKerell AD.
\newblock {{CHARMM36}} All-Atom Additive Protein Force Field: {{Validation}}
  Based on Comparison to {{NMR}} Data.
\newblock J Comput Chem.  2013 Sep; 34(25):2135--2145.
\newblock \href{10.1002/jcc.23354}{\doiprefix \detokenize{10.1002/jcc.23354}}.

\bibitem[{Maier et~al.(2015)Maier, James A. and Martinez, Carmenza and
  Kasavajhala, Koushik and Wickstrom, Lauren and Hauser, Kevin E. and
  Simmerling, Carlos}]{Maier:J.Chem.TheoryComput.:2015}
\textbf{\color{eLifeMediumGrey} Maier JA}, Martinez C, Kasavajhala K, Wickstrom
  L, Hauser KE, Simmerling C.
\newblock {{ff14SB}}: {{Improving}} the {{Accuracy}} of {{Protein Side Chain}}
  and {{Backbone Parameters}} from {{ff99SB}}.
\newblock J Chem Theory Comput.  2015 Aug; 11(8):3696--3713.
\newblock \href{10.1021/acs.jctc.5b00255}{\doiprefix
  \detokenize{10.1021/acs.jctc.5b00255}}.

\bibitem[{Harder et~al.(2016{\natexlab{a}})Harder, Edward and Damm, Wolfgang
  and Maple, Jon and Wu, Chuanjie and Reboul, Mark and Xiang, Jin Yu and Wang,
  Lingle and Lupyan, Dmitry and Dahlgren, Markus K. and Knight, Jennifer L. and
  Kaus, Joseph W. and Cerutti, David S. and Krilov, Goran and Jorgensen,
  William L. and Abel, Robert and Friesner, Richard
  A.}]{Harder:J.Chem.TheoryComput.:2016}
\textbf{\color{eLifeMediumGrey} Harder E}, Damm W, Maple J, Wu C, Reboul M,
  Xiang JY, Wang L, Lupyan D, Dahlgren MK, Knight JL, Kaus JW, Cerutti DS,
  Krilov G, Jorgensen WL, Abel R, Friesner RA.
\newblock {{OPLS3}}: {{A Force Field Providing Broad Coverage}} of
  {{Drug}}-like {{Small Molecules}} and {{Proteins}}.
\newblock J Chem Theory Comput.  2016 Jan; 12(1):281--296.
\newblock \href{10.1021/acs.jctc.5b00864}{\doiprefix
  \detokenize{10.1021/acs.jctc.5b00864}}.

\bibitem[{Cournia et~al.(2017)Cournia, Zoe and Allen, Bryce and Sherman,
  Woody}]{Cournia:2017ip}
\textbf{\color{eLifeMediumGrey} Cournia Z}, Allen B, Sherman W.
\newblock {Relative Binding Free Energy Calculations in Drug Discovery: Recent
  Advances and Practical Considerations.}
\newblock Journal of chemical information and modeling.  2017 Dec;
  57(12):2911--2937.

\bibitem[{Brown et~al.(2009)Brown, Scott P. and Muchmore, Steven W. and Hajduk,
  Philip J.}]{BROWN2009420}
\textbf{\color{eLifeMediumGrey} Brown SP}, Muchmore SW, Hajduk PJ.
\newblock Healthy Skepticism: Assessing Realistic Model Performance.
\newblock Drug Discov Today.  2009; 14(7):420 -- 427.
\newblock \href{http://dx.doi.org/10.1016/j.drudis.2009.01.012}{\doiprefix
  \detokenize{http://dx.doi.org/10.1016/j.drudis.2009.01.012}}.

\bibitem[{Abel et~al.(2017{\natexlab{a}})Abel, Robert and Mondal, Sayan and
  Masse, Craig and Greenwood, Jeremy and Harriman, Geraldine and Ashwell, Mark
  A and Bhat, Sathesh and Wester, Ronald and Frye, Leah and Kapeller, Rosana
  and Friesner, Richard A}]{Abel2017-gw}
\textbf{\color{eLifeMediumGrey} Abel R}, Mondal S, Masse C, Greenwood J,
  Harriman G, Ashwell MA, Bhat S, Wester R, Frye L, Kapeller R, Friesner RA.
\newblock Accelerating drug discovery through tight integration of expert
  molecular design and predictive scoring.
\newblock Curr Opin Struct Biol.  2017 Apr; 43(Supplement C):38--44.

\bibitem[{Lovering et~al.(2016)Lovering, Frank and Aevazelis, Cristina and
  Chang, Jeanne and Dehnhardt, Christoph and Fitz, Lori and Han, Seungil and
  Janz, Kristin and Lee, Julie and Kaila, Neelu and McDonald, Joseph and Moore,
  William and Moretto, Alessandro and Papaioannou, Nikolaos and Richard, David
  and Ryan, Mark S and Wan, Zhao-Kui and Thorarensen, Atli}]{Lovering:2016fg}
\textbf{\color{eLifeMediumGrey} Lovering F}, Aevazelis C, Chang J, Dehnhardt C,
  Fitz L, Han S, Janz K, Lee J, Kaila N, McDonald J, Moore W, Moretto A,
  Papaioannou N, Richard D, Ryan MS, Wan ZK, Thorarensen A.
\newblock {Imidazotriazines: Spleen Tyrosine Kinase (Syk) Inhibitors Identified
  by Free-Energy Perturbation (FEP).}
\newblock ChemMedChem.  2016 Jan; 11(2):217--233.

\bibitem[{Ciordia et~al.(2016)Ciordia, Myriam and P{\'e}rez-Benito, Laura and
  Delgado, Francisca and Trabanco, Andr{\'e}s A and Tresadern,
  Gary}]{Ciordia:2016dn}
\textbf{\color{eLifeMediumGrey} Ciordia M}, P{\'e}rez-Benito L, Delgado F,
  Trabanco AA, Tresadern G.
\newblock {Application of Free Energy Perturbation for the Design of BACE1
  Inhibitors.}
\newblock Journal of chemical information and modeling.  2016 Sep;
  56(9):1856--1871.

\bibitem[{Lenselink et~al.(2016)Lenselink, Eelke B and Louvel, Julien and
  Forti, Anna F and van Veldhoven, Jacobus P D and de Vries, Henk and
  Mulder-Krieger, Thea and McRobb, Fiona M and Negri, Ana and Goose, Joseph and
  Abel, Robert and van Vlijmen, Herman W T and Wang, Lingle and Harder, Edward
  and Sherman, Woody and IJzerman, Adriaan P and Beuming,
  Thijs}]{Lenselink:2016ip}
\textbf{\color{eLifeMediumGrey} Lenselink EB}, Louvel J, Forti AF, van
  Veldhoven JPD, de~Vries H, Mulder-Krieger T, McRobb FM, Negri A, Goose J,
  Abel R, van Vlijmen HWT, Wang L, Harder E, Sherman W, IJzerman AP, Beuming T.
\newblock {Predicting Binding Affinities for GPCR Ligands Using Free-Energy
  Perturbation.}
\newblock ACS omega.  2016 Aug; 1(2):293--304.

\bibitem[{Jorgensen(2016)Jorgensen, William L}]{Jorgensen:2016dv}
\textbf{\color{eLifeMediumGrey} Jorgensen WL}.
\newblock {Computer-aided discovery of anti-HIV agents.}
\newblock Bioorganic {\&} medicinal chemistry.  2016 Oct; 24(20):4768--4778.

\bibitem[{Wang et~al.(2015{\natexlab{a}})Wang, Lingle and Wu, Yujie and Deng,
  Yuqing and Kim, Byungchan and Pierce, Levi and Krilov, Goran and Lupyan,
  Dmitry and Robinson, Shaughnessy and Dahlgren, Markus K. and Greenwood,
  Jeremy and Romero, Donna L. and Masse, Craig and Knight, Jennifer L. and
  Steinbrecher, Thomas and Beuming, Thijs and Damm, Wolfgang and Harder, Ed and
  Sherman, Woody and Brewer, Mark and Wester, Ron and Murcko, Mark and Frye,
  Leah and Farid, Ramy and Lin, Teng and Mobley, David L. and Jorgensen,
  William L. and Berne, Bruce J. and Friesner, Richard A. and Abel,
  Robert}]{Wang:J.Am.Chem.Soc.:2015}
\textbf{\color{eLifeMediumGrey} Wang L}, Wu Y, Deng Y, Kim B, Pierce L, Krilov
  G, Lupyan D, Robinson S, Dahlgren MK, Greenwood J, Romero DL, Masse C, Knight
  JL, Steinbrecher T, Beuming T, Damm W, Harder E, Sherman W, Brewer M, Wester
  R, et~al.
\newblock Accurate and {{Reliable Prediction}} of {{Relative Ligand Binding
  Potency}} in {{Prospective Drug Discovery}} by {{Way}} of a {{Modern
  Free}}-{{Energy Calculation Protocol}} and {{Force Field}}.
\newblock J Am Chem Soc.  2015 Feb; 137(7):2695--2703.
\newblock \href{10.1021/ja512751q}{\doiprefix \detokenize{10.1021/ja512751q}}.

\bibitem[{Abel et~al.(2017{\natexlab{b}})Abel, Robert and Wang, Lingle and
  Harder, Edward D and Berne, B J and Friesner, Richard A}]{Abel:2017jt}
\textbf{\color{eLifeMediumGrey} Abel R}, Wang L, Harder ED, Berne BJ, Friesner
  RA.
\newblock {Advancing Drug Discovery through Enhanced Free Energy Calculations.}
\newblock Accounts of chemical research.  2017 Jul; 50(7):1625--1632.

\bibitem[{Fan et~al.(2007)Fan, Qi-Wen and Cheng, Christine K and Nicolaides,
  Theodore P and Hackett, Christopher S and Knight, Zachary A and Shokat, Kevan
  M and Weiss, William A}]{Fan2007-hm}
\textbf{\color{eLifeMediumGrey} Fan QW}, Cheng CK, Nicolaides TP, Hackett CS,
  Knight ZA, Shokat KM, Weiss WA.
\newblock A dual phosphoinositide-3-kinase {alpha/mTOR} inhibitor cooperates
  with blockade of epidermal growth factor receptor in {PTEN-mutant} glioma.
\newblock Cancer Res.  2007 Sep; 67(17):7960--7965.

\bibitem[{Kijima et~al.(2011)Kijima, Takashi and Shimizu, Tomohito and Nonen,
  Shinpei and Furukawa, Mitsugi and Otani, Yasushi and Minami, Toshiyuki and
  Takahashi, Ryo and Hirata, Haruhiko and Nagatomo, Izumi and Takeda, Yoshito
  and Kida, Hiroshi and Goya, Sho and Fujio, Yasushi and Azuma, Junichi and
  Tachibana, Isao and Kawase, Ichiro}]{Kijima2011-xs}
\textbf{\color{eLifeMediumGrey} Kijima T}, Shimizu T, Nonen S, Furukawa M,
  Otani Y, Minami T, Takahashi R, Hirata H, Nagatomo I, Takeda Y, Kida H, Goya
  S, Fujio Y, Azuma J, Tachibana I, Kawase I.
\newblock Safe and successful treatment with erlotinib after gefitinib-induced
  hepatotoxicity: difference in metabolism as a possible mechanism.
\newblock J Clin Oncol.  2011 Jul; 29(19):e588--90.

\bibitem[{Pao et~al.(2004)Pao, William and Miller, Vincent and Zakowski,
  Maureen and Doherty, Jennifer and Politi, Katerina and Sarkaria, Inderpal and
  Singh, Bhuvanesh and Heelan, Robert and Rusch, Valerie and Fulton, Lucinda
  and Mardis, Elaine and Kupfer, Doris and Wilson, Richard and Kris, Mark and
  Varmus, Harold}]{Pao2004-kx}
\textbf{\color{eLifeMediumGrey} Pao W}, Miller V, Zakowski M, Doherty J, Politi
  K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D,
  Wilson R, Kris M, Varmus H.
\newblock {EGF} receptor gene mutations are common in lung cancers from ``never
  smokers'' and are associated with sensitivity of tumors to gefitinib and
  erlotinib.
\newblock Proceedings of the National Academy of Sciences.  2004 Sep;
  101(36):13306--13311.

\bibitem[{Kim et~al.(2012)Kim, Youngjoo and Li, Zhimin and Apetri, Mihaela and
  Luo, Beibei and Settleman, Jeffrey E and Anderson, Karen S}]{Kim2012-mo}
\textbf{\color{eLifeMediumGrey} Kim Y}, Li Z, Apetri M, Luo B, Settleman JE,
  Anderson KS.
\newblock Temporal resolution of autophosphorylation for normal and oncogenic
  forms of {EGFR} and differential effects of gefitinib.
\newblock Biochemistry.  2012 Jun; 51(25):5212--5222.

\bibitem[{Juchum et~al.(2015)Juchum, Michael and G{\"u}nther, Marcel and
  Laufer, Stefan A.}]{Juchum:DrugResist.Updat.:2015}
\textbf{\color{eLifeMediumGrey} Juchum M}, G{\"u}nther M, Laufer SA.
\newblock Fighting Cancer Drug Resistance: {{Opportunities}} and Challenges for
  Mutation-Specific {{EGFR}} Inhibitors.
\newblock Drug Resist Updat.  2015 May; 20:12--28.
\newblock \href{10.1016/j.drup.2015.05.002}{\doiprefix
  \detokenize{10.1016/j.drup.2015.05.002}}.

\bibitem[{Din and Woll(2008)Din, Omar S and Woll, Penella J}]{Din2008-ag}
\textbf{\color{eLifeMediumGrey} Din OS}, Woll PJ.
\newblock Treatment of gastrointestinal stromal tumor: focus on imatinib
  mesylate.
\newblock Ther Clin Risk Manag.  2008 Feb; 4(1):149--162.

\bibitem[{Lin et~al.(2013)Lin, Yen-Lin and Meng, Yilin and Jiang, Wei and Roux,
  Beno{\^\i}t}]{Lin2013-ft}
\textbf{\color{eLifeMediumGrey} Lin YL}, Meng Y, Jiang W, Roux B.
\newblock Explaining why Gleevec is a specific and potent inhibitor of Abl
  kinase.
\newblock Proc Natl Acad Sci U S A.  2013 Jan; 110(5):1664--1669.

\bibitem[{Lin et~al.(2014)Lin, Yen-Lin and Meng, Yilin and Huang, Lei and Roux,
  Beno{\^\i}t}]{Lin2014-iv}
\textbf{\color{eLifeMediumGrey} Lin YL}, Meng Y, Huang L, Roux B.
\newblock Computational Study of Gleevec and {G6G} Reveals Molecular
  Determinants of Kinase Inhibitor Selectivity.
\newblock J Am Chem Soc.  2014 Oct; 136(42):14753--14762.

\bibitem[{Lin and Roux(2013)Lin, Yen-Lin and Roux, Beno{\^\i}t}]{Lin2013-mu}
\textbf{\color{eLifeMediumGrey} Lin YL}, Roux B.
\newblock Computational Analysis of the Binding Specificity of Gleevec to Abl,
  c-Kit, Lck, and c-Src Tyrosine Kinases.
\newblock J Am Chem Soc.  2013 Oct; 135(39):14741--14753.

\bibitem[{Aldeghi et~al.(2017)Aldeghi, Matteo and Heifetz, Alexander and
  Bodkin, Michael J and Knapp, Stefan and Biggin, Philip C}]{Aldeghi2017-ox}
\textbf{\color{eLifeMediumGrey} Aldeghi M}, Heifetz A, Bodkin MJ, Knapp S,
  Biggin PC.
\newblock Predictions of Ligand Selectivity from Absolute Binding Free Energy
  Calculations.
\newblock J Am Chem Soc.  2017 Jan; 139(2):946--957.

\bibitem[{Santos et~al.(2016)Santos, Rita and Ursu, Oleg and Gaulton, Anna and
  Bento, A. Patr?cia and Donadi, Ramesh S. and Bologa, Cristian G. and
  Karlsson, Anneli and Al-Lazikani, Bissan and Hersey, Anne and Oprea, Tudor I.
  and Overington, John P.}]{Santos:Nat.Rev.DrugDiscov.:2016}
\textbf{\color{eLifeMediumGrey} Santos R}, Ursu O, Gaulton A, Bento AP, Donadi
  RS, Bologa CG, Karlsson A, Al-Lazikani B, Hersey A, Oprea TI, Overington JP.
\newblock A Comprehensive Map of Molecular Drug Targets.
\newblock Nat Rev Drug Discov.  2016 Dec; 16(1):19--34.
\newblock \href{10.1038/nrd.2016.230}{\doiprefix
  \detokenize{10.1038/nrd.2016.230}}.

\bibitem[{Volkamer et~al.(2015{\natexlab{a}})Volkamer, Andrea and Eid, Sameh
  and Turk, Samo and Jaeger, Sabrina and Rippmann, Friedrich and Fulle,
  Simone}]{Volkamer2015-jx}
\textbf{\color{eLifeMediumGrey} Volkamer A}, Eid S, Turk S, Jaeger S, Rippmann
  F, Fulle S.
\newblock Pocketome of human kinases: prioritizing the {ATP} binding sites of
  (yet) untapped protein kinases for drug discovery.
\newblock J Chem Inf Model.  2015 Mar; 55(3):538--549.

\bibitem[{Wu et~al.(2015{\natexlab{a}})Wu, Peng and Nielsen, Thomas E and
  Clausen, Mads H}]{Wu2015-oq}
\textbf{\color{eLifeMediumGrey} Wu P}, Nielsen TE, Clausen MH.
\newblock {FDA-approved} small-molecule kinase inhibitors.
\newblock Trends Pharmacol Sci.  2015 Jul; 36(7):422--439.

\bibitem[{Volkamer et~al.(2016)Volkamer, Andrea and Eid, Sameh and Turk, Samo
  and Rippmann, Friedrich and Fulle, Simone}]{Volkamer2016-sj}
\textbf{\color{eLifeMediumGrey} Volkamer A}, Eid S, Turk S, Rippmann F, Fulle
  S.
\newblock Identification and Visualization of {Kinase-Specific} Subpockets.
\newblock J Chem Inf Model.  2016 Feb; 56(2):335--346.

\bibitem[{Christmann-Franck et~al.(2016)Christmann-Franck, Serge and van
  Westen, Gerard J P and Papadatos, George and Beltran Escudie, Fanny and
  Roberts, Alexander and Overington, John P and Domine,
  Daniel}]{ChristmannFranck:2016gka}
\textbf{\color{eLifeMediumGrey} Christmann-Franck S}, van Westen GJP, Papadatos
  G, Beltran~Escudie F, Roberts A, Overington JP, Domine D.
\newblock {Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate
  Prediction of Compound{\textendash}Kinase Activities: A Way toward Selective
  Promiscuity by Design?}
\newblock Journal of chemical information and modeling.  2016 Sep;
  56(9):1654--1675.

\bibitem[{Anastassiadis et~al.(2011)Anastassiadis, Theonie and Deacon, Sean W
  and Devarajan, Karthik and Ma, Haiching and Peterson, Jeffrey
  R}]{Anastassiadis2011-sm}
\textbf{\color{eLifeMediumGrey} Anastassiadis T}, Deacon SW, Devarajan K, Ma H,
  Peterson JR.
\newblock Comprehensive assay of kinase catalytic activity reveals features of
  kinase inhibitor selectivity.
\newblock Nat Biotechnol.  2011 Nov; 29(11):1039--1045.

\bibitem[{Klaeger et~al.(2017)Klaeger, Susan and Heinzlmeir, Stephanie and
  Wilhelm, Mathias and Polzer, Harald and Vick, Binje and Koenig, Paul-Albert
  and Reinecke, Maria and Ruprecht, Benjamin and Petzoldt, Svenja and Meng,
  Chen and Zecha, Jana and Reiter, Katrin and Qiao, Huichao and Helm, Dominic
  and Koch, Heiner and Schoof, Melanie and Canevari, Giulia and Casale, Elena
  and Depaolini, Stefania Re and Feuchtinger, Annette and Wu, Zhixiang and
  Schmidt, Tobias and Rueckert, Lars and Becker, Wilhelm and Huenges, Jan and
  Garz, Anne-Kathrin and Gohlke, Bjoern-Oliver and Zolg, Daniel Paul and
  Kayser, Gian and Vooder, Tonu and Preissner, Robert and Hahne, Hannes and
  T{\~o}nisson, Neeme and Kramer, Karl and G{\"o}tze, Katharina and Bassermann,
  Florian and Schlegl, Judith and Ehrlich, Hans-Christian and Aiche, Stephan
  and Walch, Axel and Greif, Philipp A and Schneider, Sabine and Felder, Eduard
  Rudolf and Ruland, Juergen and M{\'e}dard, Guillaume and Jeremias, Irmela and
  Spiekermann, Karsten and Kuster, Bernhard}]{Klaeger2017-jr}
\textbf{\color{eLifeMediumGrey} Klaeger S}, Heinzlmeir S, Wilhelm M, Polzer H,
  Vick B, Koenig PA, Reinecke M, Ruprecht B, Petzoldt S, Meng C, Zecha J,
  Reiter K, Qiao H, Helm D, Koch H, Schoof M, Canevari G, Casale E, Depaolini
  SR, Feuchtinger A, et~al.
\newblock The target landscape of clinical kinase drugs.
\newblock Science.  2017 Dec; 358(6367).

\bibitem[{Sun et~al.(2014)Sun, Chong and Hobor, Sebastijan and Bertotti, Andrea
  and Zecchin, Davide and Huang, Sidong and Galimi, Francesco and Cottino,
  Francesca and Prahallad, Anirudh and Grernrum, Wipawadee and Tzani, Anna and
  Schlicker, Andreas and Wessels, Lodewyk F A and Smit, Egbert F and
  Thunnissen, Erik and Halonen, Pasi and Lieftink, Cor and Beijersbergen,
  Roderick L and Di Nicolantonio, Federica and Bardelli, Alberto and Trusolino,
  Livio and Bernards, Ren{\'e}}]{Sun:2014kt}
\textbf{\color{eLifeMediumGrey} Sun C}, Hobor S, Bertotti A, Zecchin D, Huang
  S, Galimi F, Cottino F, Prahallad A, Grernrum W, Tzani A, Schlicker A,
  Wessels LFA, Smit EF, Thunnissen E, Halonen P, Lieftink C, Beijersbergen RL,
  Di~Nicolantonio F, Bardelli A, Trusolino L, et~al.
\newblock {Intrinsic resistance to MEK inhibition in KRAS mutant lung and colon
  cancer through transcriptional induction of ERBB3.}
\newblock CellReports.  2014 Apr; 7(1):86--93.

\bibitem[{Manchado et~al.(2016)Manchado, Eusebio and Weissmueller, Susann and
  Morris, John P and Chen, Chi-Chao and Wullenkord, Ramona and Lujambio, Amaia
  and de Stanchina, Elisa and Poirier, John T and Gainor, Justin F and
  Corcoran, Ryan B and Engelman, Jeffrey A and Rudin, Charles M and Rosen, Neal
  and Lowe, Scott W}]{Manchado:2016fb}
\textbf{\color{eLifeMediumGrey} Manchado E}, Weissmueller S, Morris JP, Chen
  CC, Wullenkord R, Lujambio A, de~Stanchina E, Poirier JT, Gainor JF, Corcoran
  RB, Engelman JA, Rudin CM, Rosen N, Lowe SW.
\newblock {A combinatorial strategy for treating KRAS-mutant lung cancer.}
\newblock Nature.  2016 Jun; 534(7609):647--651.

\bibitem[{Shao et~al.(2013)Shao, Hao and Shi, Shenhua and Huang, Shiliang and
  Hole, Alison J and Abbas, Abdullahi Y and Baumli, Sonja and Liu, Xiangrui and
  Lam, Frankie and Foley, David W and Fischer, Peter M and Noble, Martin and
  Endicott, Jane A and Pepper, Chris and Wang, Shudong}]{Shao2013-oe}
\textbf{\color{eLifeMediumGrey} Shao H}, Shi S, Huang S, Hole AJ, Abbas AY,
  Baumli S, Liu X, Lam F, Foley DW, Fischer PM, Noble M, Endicott JA, Pepper C,
  Wang S.
\newblock Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly
  Active {CDK9} Inhibitors: Synthesis, X-ray Crystal Structures,
  {Structure--Activity} Relationship, and Anticancer Activities.
\newblock J Med Chem.  2013 Feb; 56(3):640--659.

\bibitem[{Blake et~al.(2016)Blake, James F and Burkard, Michael and Chan,
  Jocelyn and Chen, Huifen and Chou, Kang-Jye and Diaz, Dolores and Dudley,
  Danette A and Gaudino, John J and Gould, Stephen E and Grina, Jonas and
  Hunsaker, Thomas and Liu, Lichuan and Martinson, Matthew and Moreno, David
  and Mueller, Lars and Orr, Christine and Pacheco, Patricia and Qin, Ann and
  Rasor, Kevin and Ren, Li and Robarge, Kirk and Shahidi-Latham, Sheerin and
  Stults, Jeffrey and Sullivan, Francis and Wang, Weiru and Yin, Jianping and
  Zhou, Aihe and Belvin, Marcia and Merchant, Mark and Moffat, John and
  Schwarz, Jacob B}]{Blake2016-su}
\textbf{\color{eLifeMediumGrey} Blake JF}, Burkard M, Chan J, Chen H, Chou KJ,
  Diaz D, Dudley DA, Gaudino JJ, Gould SE, Grina J, Hunsaker T, Liu L,
  Martinson M, Moreno D, Mueller L, Orr C, Pacheco P, Qin A, Rasor K, Ren L,
  et~al.
\newblock Discovery of
  ({S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one}
  ({GDC-0994)}, an Extracellular {Signal-Regulated} Kinase 1/2 ({ERK1/2})
  Inhibitor in Early Clinical Development.
\newblock J Med Chem.  2016 Jun; 59(12):5650--5660.

\bibitem[{Hole et~al.(2013)Hole, Alison J and Baumli, Sonja and Shao, Hao and
  Shi, Shenhua and Huang, Shiliang and Pepper, Chris and Fischer, Peter M and
  Wang, Shudong and Endicott, Jane A and Noble, Martin E}]{Hole2013-sr}
\textbf{\color{eLifeMediumGrey} Hole AJ}, Baumli S, Shao H, Shi S, Huang S,
  Pepper C, Fischer PM, Wang S, Endicott JA, Noble ME.
\newblock Comparative Structural and Functional Studies of
  4-(Thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile {CDK9} Inhibitors
  Suggest the Basis for Isotype Selectivity.
\newblock J Med Chem.  2013 Feb; 56(3):660--670.

\bibitem[{Berman et~al.(2002)Berman, Helen M and Battistuz, Tammy and Bhat, T N
  and Bluhm, Wolfgang F and Bourne, Philip E and Burkhardt, Kyle and Feng,
  Zukang and Gilliland, Gary L and Iype, Lisa and Jain, Shri and Fagan, Phoebe
  and Marvin, Jessica and Padilla, David and Ravichandran, Veerasamy and
  Schneider, Bohdan and Thanki, Narmada and Weissig, Helge and Westbrook, John
  D and Zardecki, Christine}]{Berman2002-hg}
\textbf{\color{eLifeMediumGrey} Berman HM}, Battistuz T, Bhat TN, Bluhm WF,
  Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin
  J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD,
  Zardecki C.
\newblock The Protein Data Bank.
\newblock Acta Crystallogr D Biol Crystallogr.  2002 Jun; 58(Pt 61):899--907.

\bibitem[{Sastry et~al.(2013)Sastry, G Madhavi and Adzhigirey, Matvey and Day,
  Tyler and Annabhimoju, Ramakrishna and Sherman, Woody}]{Sastry2013-ax}
\textbf{\color{eLifeMediumGrey} Sastry GM}, Adzhigirey M, Day T, Annabhimoju R,
  Sherman W.
\newblock Protein and ligand preparation: parameters, protocols, and influence
  on virtual screening enrichments.
\newblock J Comput Aided Mol Des.  2013 Mar; 27(3):221--234.

\bibitem[{Harder et~al.(2016{\natexlab{b}})Harder, Edward and Damm, Wolfgang
  and Maple, Jon and Wu, Chuanjie and Reboul, Mark and Xiang, Jin Yu and Wang,
  Lingle and Lupyan, Dmitry and Dahlgren, Markus K and Knight, Jennifer L and
  Kaus, Joseph W and Cerutti, David S and Krilov, Goran and Jorgensen, William
  L and Abel, Robert and Friesner, Richard A}]{Harder2016-zn}
\textbf{\color{eLifeMediumGrey} Harder E}, Damm W, Maple J, Wu C, Reboul M,
  Xiang JY, Wang L, Lupyan D, Dahlgren MK, Knight JL, Kaus JW, Cerutti DS,
  Krilov G, Jorgensen WL, Abel R, Friesner RA.
\newblock {OPLS3}: A Force Field Providing Broad Coverage of Drug-like Small
  Molecules and Proteins.
\newblock J Chem Theory Comput.  2016 Jan; 12(1):281--296.

\bibitem[{Bochevarov et~al.(2013)Bochevarov, Art D and Harder, Edward and
  Hughes, Thomas F and Greenwood, Jeremy R and Braden, Dale A and Philipp, Dean
  M and Rinaldo, David and Halls, Mathew D and Zhang, Jing and Friesner,
  Richard A}]{Bochevarov2013-bn}
\textbf{\color{eLifeMediumGrey} Bochevarov AD}, Harder E, Hughes TF, Greenwood
  JR, Braden DA, Philipp DM, Rinaldo D, Halls MD, Zhang J, Friesner RA.
\newblock Jaguar: a high-performance quantum chemistry software program with
  strengths in life and materials sciences.
\newblock Int J Quantum Chem.  2013; 113(18):2110--2142.

\bibitem[{Salvatier et~al.(2016)Salvatier, John and Wiecki, Thomas V and
  Fonnesbeck, Christopher}]{Salvatier:2016ki}
\textbf{\color{eLifeMediumGrey} Salvatier J}, Wiecki TV, Fonnesbeck C.
\newblock {Probabilistic programming in Python using PyMC3}.
\newblock PeerJ Computer Science.  2016; 2:e55.

\bibitem[{Al-Rfou et~al.(2016)Rami Al-Rfou and Guillaume Alain and Amjad
  Almahairi and Christof Angermueller and Dzmitry Bahdanau and Nicolas Ballas
  and Fr\'ed\'eric Bastien and Justin Bayer and Anatoly Belikov and Alexander
  Belopolsky and Yoshua Bengio and Arnaud Bergeron and James Bergstra and
  Valentin Bisson and Josh {Bleecher Snyder} and Nicolas Bouchard and Nicolas
  Boulanger-Lewandowski and Xavier Bouthillier and Alexandre de Br\'ebisson and
  Olivier Breuleux and Pierre-Luc Carrier and Kyunghyun Cho and Jan Chorowski
  and Paul Christiano and Tim Cooijmans and Marc-Alexandre C\^ot\'e and Myriam
  C\^ot\'e and Aaron Courville and Yann N. Dauphin and Olivier Delalleau and
  Julien Demouth and Guillaume Desjardins and Sander Dieleman and Laurent Dinh
  and M\'elanie Ducoffe and Vincent Dumoulin and Samira {Ebrahimi Kahou} and
  Dumitru Erhan and Ziye Fan and Orhan Firat and Mathieu Germain and Xavier
  Glorot and Ian Goodfellow and Matt Graham and Caglar Gulcehre and Philippe
  Hamel and Iban Harlouchet and Jean-Philippe Heng and Bal\'azs Hidasi and Sina
  Honari and Arjun Jain and S\'ebastien Jean and Kai Jia and Mikhail Korobov
  and Vivek Kulkarni and Alex Lamb and Pascal Lamblin and Eric Larsen and
  C\'esar Laurent and Sean Lee and Simon Lefrancois and Simon Lemieux and
  Nicholas L\'eonard and Zhouhan Lin and Jesse A. Livezey and Cory Lorenz and
  Jeremiah Lowin and Qianli Ma and Pierre-Antoine Manzagol and Olivier
  Mastropietro and Robert T. McGibbon and Roland Memisevic and Bart van
  Merri\"enboer and Vincent Michalski and Mehdi Mirza and Alberto Orlandi and
  Christopher Pal and Razvan Pascanu and Mohammad Pezeshki and Colin Raffel and
  Daniel Renshaw and Matthew Rocklin and Adriana Romero and Markus Roth and
  Peter Sadowski and John Salvatier and Fran\c{c}ois Savard and Jan Schl\"uter
  and John Schulman and Gabriel Schwartz and Iulian Vlad Serban and Dmitriy
  Serdyuk and Samira Shabanian and \'Etienne Simon and Sigurd Spieckermann and
  S. Ramana Subramanyam and Jakub Sygnowski and J\'er\'emie Tanguay and Gijs
  van Tulder and Joseph Turian and Sebastian Urban and Pascal Vincent and
  Francesco Visin and Harm de Vries and David Warde-Farley and Dustin J. Webb
  and Matthew Willson and Kelvin Xu and Lijun Xue and Li Yao and Saizheng Zhang
  and Ying Zhang}]{2016arXiv160502688full}
\textbf{\color{eLifeMediumGrey} Al-Rfou R}, Alain G, Almahairi A, Angermueller
  C, Bahdanau D, Ballas N, Bastien F, Bayer J, Belikov A, Belopolsky A, Bengio
  Y, Bergeron A, Bergstra J, Bisson V, {Bleecher Snyder} J, Bouchard N,
  Boulanger-Lewandowski N, Bouthillier X, de~Br\'ebisson A, Breuleux O, et~al.
\newblock {Theano: A {Python} framework for fast computation of mathematical
  expressions}.
\newblock arXiv e-prints.  2016 May; abs/1605.02688.
\newblock \urlprefix\url{http://arxiv.org/abs/1605.02688}.

\bibitem[{Bosc et~al.(2017)Bosc, Nicolas and Meyer, Christophe and Bonnet,
  Pascal}]{Bosc:2017gs}
\textbf{\color{eLifeMediumGrey} Bosc N}, Meyer C, Bonnet P.
\newblock {The use of novel selectivity metrics in kinase research.}
\newblock BMC bioinformatics.  2017 Jan; 18(1):17.

\bibitem[{Cheng et~al.(2010)Cheng, Alan C and Eksterowicz, John and
  Geuns-Meyer, Stephanie and Sun, Yaxiong}]{Cheng2010-ip}
\textbf{\color{eLifeMediumGrey} Cheng AC}, Eksterowicz J, Geuns-Meyer S, Sun Y.
\newblock Analysis of kinase inhibitor selectivity using a thermodynamics-based
  partition index.
\newblock J Med Chem.  2010 Jun; 53(11):4502--4510.

\bibitem[{Hauser et~al.(2018)Hauser, Kevin and Negron, Christopher and
  Albanese, Steven K and Ray, Soumya and Steinbrecher, Thomas and Abel, Robert
  and Chodera, John D and Wang, Lingle}]{Hauser:2018vz}
\textbf{\color{eLifeMediumGrey} Hauser K}, Negron C, Albanese SK, Ray S,
  Steinbrecher T, Abel R, Chodera JD, Wang L.
\newblock {Predicting resistance of clinical Abl mutations to targeted kinase
  inhibitors using alchemical free-energy calculations}.
\newblock Communications Biology.  2018 Jun; 1(1):70.

\bibitem[{Hari et~al.(2013)Hari, Sanjay B and Merritt, Ethan A and Maly, Dustin
  J}]{Hari:2013dp}
\textbf{\color{eLifeMediumGrey} Hari SB}, Merritt EA, Maly DJ.
\newblock {Sequence determinants of a specific inactive protein kinase
  conformation.}
\newblock Chemistry {\&} biology.  2013 Jun; 20(6):806--815.

\bibitem[{Hu et~al.(2015)Hu, Jiancheng and Ahuja, Lalima G and Meharena, Hiruy
  S and Kannan, Natarajan and Kornev, Alexandr P and Taylor, Susan S and Shaw,
  Andrey S}]{Hu:2015kh}
\textbf{\color{eLifeMediumGrey} Hu J}, Ahuja LG, Meharena HS, Kannan N, Kornev
  AP, Taylor SS, Shaw AS.
\newblock {Kinase regulation by hydrophobic spine assembly in cancer.}
\newblock Molecular and cellular biology.  2015 Jan; 35(1):264--276.

\bibitem[{Laplante and Sabatini(2012)Laplante, Mathieu and Sabatini, David
  M}]{Laplante:2012fm}
\textbf{\color{eLifeMediumGrey} Laplante M}, Sabatini DM.
\newblock {mTOR signaling in growth control and disease.}
\newblock Cell.  2012 Apr; 149(2):274--293.

\bibitem[{Saxton and Sabatini(2017)Saxton, Robert A and Sabatini, David
  M}]{Saxton:2017cv}
\textbf{\color{eLifeMediumGrey} Saxton RA}, Sabatini DM.
\newblock {mTOR Signaling in Growth, Metabolism, and Disease.}
\newblock Cell.  2017 Mar; 168(6):960--976.

\bibitem[{Kim et~al.(2002)Kim, Do-Hyung and Sarbassov, D D and Ali, Siraj M and
  King, Jessie E and Latek, Robert R and Erdjument-Bromage, Hediye and Tempst,
  Paul and Sabatini, David M}]{Kim:2002vh}
\textbf{\color{eLifeMediumGrey} Kim DH}, Sarbassov DD, Ali SM, King JE, Latek
  RR, Erdjument-Bromage H, Tempst P, Sabatini DM.
\newblock {mTOR interacts with raptor to form a nutrient-sensitive complex that
  signals to the cell growth machinery.}
\newblock Cell.  2002 Jul; 110(2):163--175.

\bibitem[{Hara et~al.(2002)Hara, Kenta and Maruki, Yoshiko and Long, Xiaomeng
  and Yoshino, Ken-ichi and Oshiro, Noriko and Hidayat, Sujuti and Tokunaga,
  Chiharu and Avruch, Joseph and Yonezawa, Kazuyoshi}]{Hara:2002tn}
\textbf{\color{eLifeMediumGrey} Hara K}, Maruki Y, Long X, Yoshino Ki, Oshiro
  N, Hidayat S, Tokunaga C, Avruch J, Yonezawa K.
\newblock {Raptor, a binding partner of target of rapamycin (TOR), mediates TOR
  action.}
\newblock Cell.  2002 Jul; 110(2):177--189.

\bibitem[{Yang et~al.(2017)Yang, Haijuan and Jiang, Xiaolu and Li, Buren and
  Yang, Hyo J and Miller, Meredith and Yang, Angela and Dhar, Ankita and
  Pavletich, Nikola P}]{Yang:2017gu}
\textbf{\color{eLifeMediumGrey} Yang H}, Jiang X, Li B, Yang HJ, Miller M, Yang
  A, Dhar A, Pavletich NP.
\newblock {Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40.}
\newblock Nature.  2017 Dec; 552(7685):368--373.

\bibitem[{Sarbassov et~al.(2004)Sarbassov, D D and Ali, Siraj M and Kim,
  Do-Hyung and Guertin, David A and Latek, Robert R and Erdjument-Bromage,
  Hediye and Tempst, Paul and Sabatini, David M}]{Sarbassov:2004kv}
\textbf{\color{eLifeMediumGrey} Sarbassov DD}, Ali SM, Kim DH, Guertin DA,
  Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM.
\newblock {Rictor, a novel binding partner of mTOR, defines a
  rapamycin-insensitive and raptor-independent pathway that regulates the
  cytoskeleton.}
\newblock Current biology : CB.  2004 Jul; 14(14):1296--1302.

\bibitem[{Bar-Peled and Sabatini(2012)Bar-Peled, Liron and Sabatini, David
  M}]{BarPeled:2012gq}
\textbf{\color{eLifeMediumGrey} Bar-Peled L}, Sabatini DM.
\newblock {SnapShot: mTORC1 signaling at the lysosomal surface.}
\newblock Cell.  2012 Dec; 151(6):1390--1390.e1.

\bibitem[{Peterson et~al.(2009)Peterson, Timothy R and Laplante, Mathieu and
  Thoreen, Carson C and Sancak, Yasemin and Kang, Seong A and Kuehl, W Michael
  and Gray, Nathanael S and Sabatini, David M}]{Peterson:2009fc}
\textbf{\color{eLifeMediumGrey} Peterson TR}, Laplante M, Thoreen CC, Sancak Y,
  Kang SA, Kuehl WM, Gray NS, Sabatini DM.
\newblock {DEPTOR is an mTOR inhibitor frequently overexpressed in multiple
  myeloma cells and required for their survival.}
\newblock Cell.  2009 May; 137(5):873--886.

\bibitem[{Yang et~al.(2013)Yang, Haijuan and Rudge, Derek G and Koos, Joseph D
  and Vaidialingam, Bhamini and Yang, Hyo J and Pavletich, Nikola
  P}]{Yang:2013gaa}
\textbf{\color{eLifeMediumGrey} Yang H}, Rudge DG, Koos JD, Vaidialingam B,
  Yang HJ, Pavletich NP.
\newblock {mTOR kinase structure, mechanism and regulation.}
\newblock Nature.  2013 May; 497(7448):217--223.

\bibitem[{Gaubitz et~al.(2015)Gaubitz, Christl and Oliveira, Taiana M and
  Prouteau, Manoel and Leitner, Alexander and Karuppasamy, Manikandan and
  Konstantinidou, Georgia and Rispal, Delphine and Eltschinger, Sandra and
  Robinson, Graham C and Thore, St{\'e}phane and Aebersold, Ruedi and
  Schaffitzel, Christiane and Loewith, Robbie}]{Gaubitz:2015gr}
\textbf{\color{eLifeMediumGrey} Gaubitz C}, Oliveira TM, Prouteau M, Leitner A,
  Karuppasamy M, Konstantinidou G, Rispal D, Eltschinger S, Robinson GC, Thore
  S, Aebersold R, Schaffitzel C, Loewith R.
\newblock {Molecular Basis of the Rapamycin Insensitivity of Target Of
  Rapamycin Complex 2.}
\newblock Molecular cell.  2015 Jun; 58(6):977--988.

\bibitem[{Aylett et~al.(2016)Aylett, Christopher H S and Sauer, Evelyn and
  Imseng, Stefan and Boehringer, Daniel and Hall, Michael N and Ban, Nenad and
  Maier, Timm}]{Aylett:2016gs}
\textbf{\color{eLifeMediumGrey} Aylett CHS}, Sauer E, Imseng S, Boehringer D,
  Hall MN, Ban N, Maier T.
\newblock {Architecture of human mTOR complex 1.}
\newblock Science.  2016 Jan; 351(6268):48--52.

\bibitem[{Inoki et~al.(2002)Inoki, Ken and Li, Yong and Zhu, Tianquan and Wu,
  Jun and Guan, Kun-Liang}]{Inoki:2002jv}
\textbf{\color{eLifeMediumGrey} Inoki K}, Li Y, Zhu T, Wu J, Guan KL.
\newblock {TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR
  signalling.}
\newblock Nature cell biology.  2002 Sep; 4(9):648--657.

\bibitem[{Manning et~al.(2002{\natexlab{b}})Manning, Brendan D and Tee, Andrew
  R and Logsdon, M Nicole and Blenis, John and Cantley, Lewis
  C}]{Manning:2002tp}
\textbf{\color{eLifeMediumGrey} Manning BD}, Tee AR, Logsdon MN, Blenis J,
  Cantley LC.
\newblock {Identification of the tuberous sclerosis complex-2 tumor suppressor
  gene product tuberin as a target of the phosphoinositide 3-kinase/akt
  pathway.}
\newblock Molecular cell.  2002 Jul; 10(1):151--162.

\bibitem[{Jones et~al.(2005)Jones, Russell G and Plas, David R and Kubek, Sara
  and Buzzai, Monica and Mu, James and Xu, Yang and Birnbaum, Morris J and
  Thompson, Craig B}]{Jones:2005kg}
\textbf{\color{eLifeMediumGrey} Jones RG}, Plas DR, Kubek S, Buzzai M, Mu J, Xu
  Y, Birnbaum MJ, Thompson CB.
\newblock {AMP-activated protein kinase induces a p53-dependent metabolic
  checkpoint.}
\newblock Molecular cell.  2005 Apr; 18(3):283--293.

\bibitem[{Inoki et~al.(2003)Inoki, Ken and Li, Yong and Xu, Tian and Guan,
  Kun-Liang}]{Inoki:2003je}
\textbf{\color{eLifeMediumGrey} Inoki K}, Li Y, Xu T, Guan KL.
\newblock {Rheb GTPase is a direct target of TSC2 GAP activity and regulates
  mTOR signaling.}
\newblock Genes {\&} development.  2003 Aug; 17(15):1829--1834.

\bibitem[{Bar-Peled et~al.(2012)Bar-Peled, Liron and Schweitzer, Lawrence D and
  Zoncu, Roberto and Sabatini, David M}]{BarPeled:2012fr}
\textbf{\color{eLifeMediumGrey} Bar-Peled L}, Schweitzer LD, Zoncu R, Sabatini
  DM.
\newblock {Ragulator is a GEF for the rag GTPases that signal amino acid levels
  to mTORC1.}
\newblock Cell.  2012 Sep; 150(6):1196--1208.

\bibitem[{Kim et~al.(2008)Kim, Eunjung and Goraksha-Hicks, Pankuri and Li, Li
  and Neufeld, Thomas P and Guan, Kun-Liang}]{Kim:2008kb}
\textbf{\color{eLifeMediumGrey} Kim E}, Goraksha-Hicks P, Li L, Neufeld TP,
  Guan KL.
\newblock {Regulation of TORC1 by Rag GTPases in nutrient response.}
\newblock Nature cell biology.  2008 Aug; 10(8):935--945.

\bibitem[{Sancak et~al.(2010)Sancak, Yasemin and Bar-Peled, Liron and Zoncu,
  Roberto and Markhard, Andrew L and Nada, Shigeyuki and Sabatini, David
  M}]{Sancak:2010bu}
\textbf{\color{eLifeMediumGrey} Sancak Y}, Bar-Peled L, Zoncu R, Markhard AL,
  Nada S, Sabatini DM.
\newblock {Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is
  necessary for its activation by amino acids.}
\newblock Cell.  2010 Apr; 141(2):290--303.

\bibitem[{Efeyan et~al.(2012)Efeyan, Alejo and Zoncu, Roberto and Sabatini,
  David M}]{Efeyan:2012de}
\textbf{\color{eLifeMediumGrey} Efeyan A}, Zoncu R, Sabatini DM.
\newblock {Amino acids and mTORC1: from lysosomes to disease.}
\newblock Trends in molecular medicine.  2012 Sep; 18(9):524--533.

\bibitem[{Hay and Sonenberg(2004)Hay, Nissim and Sonenberg, Nahum}]{Hay:2004ir}
\textbf{\color{eLifeMediumGrey} Hay N}, Sonenberg N.
\newblock {Upstream and downstream of mTOR.}
\newblock Genes {\&} development.  2004 Aug; 18(16):1926--1945.

\bibitem[{Lamming and Sabatini(2013)Lamming, Dudley W and Sabatini, David
  M}]{Lamming:2013dza}
\textbf{\color{eLifeMediumGrey} Lamming DW}, Sabatini DM.
\newblock {A Central role for mTOR in lipid homeostasis.}
\newblock Cell metabolism.  2013 Oct; 18(4):465--469.

\bibitem[{Delarue et~al.(2018)Delarue, M and Brittingham, G P and Pfeffer, S
  and Surovtsev, I V and Pinglay, S and Kennedy, K J and Schaffer, M and
  Gutierrez, J I and Sang, D and Poterewicz, G and Chung, J K and Plitzko, J M
  and Groves, J T and Jacobs-Wagner, C and Engel, B D and Holt, L
  J}]{Delarue:2018ca}
\textbf{\color{eLifeMediumGrey} Delarue M}, Brittingham GP, Pfeffer S,
  Surovtsev IV, Pinglay S, Kennedy KJ, Schaffer M, Gutierrez JI, Sang D,
  Poterewicz G, Chung JK, Plitzko JM, Groves JT, Jacobs-Wagner C, Engel BD,
  Holt LJ.
\newblock {mTORC1 Controls Phase Separation and the Biophysical Properties of
  the Cytoplasm by Tuning Crowding}.
\newblock Cell.  2018 Jun; .

\bibitem[{Ballou and Lin(2008)Ballou, Lisa M and Lin, Richard
  Z}]{Ballou:2008ec}
\textbf{\color{eLifeMediumGrey} Ballou LM}, Lin RZ.
\newblock {Rapamycin and mTOR kinase inhibitors.}
\newblock Journal of chemical biology.  2008 Nov; 1(1-4):27--36.

\bibitem[{Lamming et~al.(2013)Lamming, Dudley W and Ye, Lan and Sabatini, David
  M and Baur, Joseph A}]{Lamming:2013kg}
\textbf{\color{eLifeMediumGrey} Lamming DW}, Ye L, Sabatini DM, Baur JA.
\newblock {Rapalogs and mTOR inhibitors as anti-aging therapeutics.}
\newblock The Journal of clinical investigation.  2013 Mar; 123(3):980--989.

\bibitem[{Hudes et~al.(2007)Hudes, Gary and Carducci, Michael and Tomczak,
  Piotr and Dutcher, Janice and Figlin, Robert and Kapoor, Anil and
  Staroslawska, Elzbieta and Sosman, Jeffrey and McDermott, David and Bodrogi,
  Istv{\'a}n and Kovacevic, Zoran and Lesovoy, Vladimir and Schmidt-Wolf, Ingo
  G H and Barbarash, Olga and Gokmen, Erhan and O'Toole, Timothy and
  Lustgarten, Stephanie and Moore, Laurence and Motzer, Robert J and {Global
  ARCC Trial}}]{Hudes:2007kp}
\textbf{\color{eLifeMediumGrey} Hudes G}, Carducci M, Tomczak P, Dutcher J,
  Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I,
  Kovacevic Z, Lesovoy V, Schmidt-Wolf IGH, Barbarash O, Gokmen E, O'Toole T,
  Lustgarten S, Moore L, Motzer RJ, {Global ARCC Trial}.
\newblock {Temsirolimus, interferon alfa, or both for advanced renal-cell
  carcinoma.}
\newblock The New England journal of medicine.  2007 May; 356(22):2271--2281.

\bibitem[{Motzer et~al.(2008)Motzer, Robert J and Escudier, Bernard and Oudard,
  St{\'e}phane and Hutson, Thomas E and Porta, Camillo and Bracarda, Sergio and
  Gr{\"u}nwald, Viktor and Thompson, John A and Figlin, Robert A and
  Hollaender, Norbert and Urbanowitz, Gladys and Berg, William J and Kay,
  Andrea and Lebwohl, David and Ravaud, Alain and {RECORD-1 Study
  Group}}]{Motzer:2008cn}
\textbf{\color{eLifeMediumGrey} Motzer RJ}, Escudier B, Oudard S, Hutson TE,
  Porta C, Bracarda S, Gr{\"u}nwald V, Thompson JA, Figlin RA, Hollaender N,
  Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A, {RECORD-1 Study Group}.
\newblock {Efficacy of everolimus in advanced renal cell carcinoma: a
  double-blind, randomised, placebo-controlled phase III trial.}
\newblock Lancet (London, England).  2008 Aug; 372(9637):449--456.

\bibitem[{Hausch et~al.(2013)Hausch, Felix and Kozany, Christian and
  Theodoropoulou, Marily and Fabian, Anne-Katrin}]{Hausch:2013iu}
\textbf{\color{eLifeMediumGrey} Hausch F}, Kozany C, Theodoropoulou M, Fabian
  AK.
\newblock {FKBPs and the Akt/mTOR pathway.}
\newblock Cell cycle (Georgetown, Tex).  2013 Aug; 12(15):2366--2370.

\bibitem[{Yip et~al.(2010)Yip, Calvin K and Murata, Kazuyoshi and Walz, Thomas
  and Sabatini, David M and Kang, Seong A}]{Yip:2010bm}
\textbf{\color{eLifeMediumGrey} Yip CK}, Murata K, Walz T, Sabatini DM, Kang
  SA.
\newblock {Structure of the human mTOR complex I and its implications for
  rapamycin inhibition.}
\newblock Molecular cell.  2010 Jun; 38(5):768--774.

\bibitem[{Schreiber et~al.(2015)Schreiber, Katherine H and Ortiz, Denise and
  Academia, Emmeline C and Anies, Arieanna C and Liao, Chen-Yu and Kennedy,
  Brian K}]{Schreiber:2015fi}
\textbf{\color{eLifeMediumGrey} Schreiber KH}, Ortiz D, Academia EC, Anies AC,
  Liao CY, Kennedy BK.
\newblock {Rapamycin-mediated mTORC2 inhibition is determined by the relative
  expression of FK506-binding proteins.}
\newblock Aging cell.  2015 Apr; 14(2):265--273.

\bibitem[{Slotkin et~al.(2015)Slotkin, Emily K and Patwardhan, Parag P and
  Vasudeva, Shyamprasad D and de Stanchina, Elisa and Tap, William D and
  Schwartz, Gary K}]{Slotkin:2015je}
\textbf{\color{eLifeMediumGrey} Slotkin EK}, Patwardhan PP, Vasudeva SD,
  de~Stanchina E, Tap WD, Schwartz GK.
\newblock {MLN0128, an ATP-competitive mTOR kinase inhibitor with potent in
  vitro and in vivo antitumor activity, as potential therapy for bone and
  soft-tissue sarcoma.}
\newblock Molecular cancer therapeutics.  2015 Feb; 14(2):395--406.

\bibitem[{Hassan et~al.(2014)Hassan, Burhan and Akcakanat, Argun and Sangai,
  Takafumi and Evans, Kurt W and Adkins, Farrell and Eterovic, Agda Karina and
  Zhao, Hao and Chen, Ken and Chen, Huiqin and Do, Kim-Anh and Xie, Shelly M
  and Holder, Ashley M and Naing, Aung and Mills, Gordon B and Meric-Bernstam,
  Funda}]{Hassan:2014kl}
\textbf{\color{eLifeMediumGrey} Hassan B}, Akcakanat A, Sangai T, Evans KW,
  Adkins F, Eterovic AK, Zhao H, Chen K, Chen H, Do KA, Xie SM, Holder AM,
  Naing A, Mills GB, Meric-Bernstam F.
\newblock {Catalytic mTOR inhibitors can overcome intrinsic and acquired
  resistance to allosteric mTOR inhibitors.}
\newblock Oncotarget.  2014 Sep; 5(18):8544--8557.

\bibitem[{Garc{\'\i}a-Garc{\'\i}a et~al.(2012)Garc{\'\i}a-Garc{\'\i}a, Celina
  and Ibrahim, Yasir H and Serra, Violeta and Calvo, Maria Teresa and
  Guzm{\'a}n, Marta and Grueso, Judit and Aura, Claudia and P{\'e}rez, Jos{\'e}
  and Jessen, Katti and Liu, Yi and Rommel, Christian and Tabernero, Josep and
  Baselga, Jos{\'e} and Scaltriti, Maurizio}]{GarciaGarcia:2012jc}
\textbf{\color{eLifeMediumGrey} Garc{\'\i}a-Garc{\'\i}a C}, Ibrahim YH, Serra
  V, Calvo MT, Guzm{\'a}n M, Grueso J, Aura C, P{\'e}rez J, Jessen K, Liu Y,
  Rommel C, Tabernero J, Baselga J, Scaltriti M.
\newblock {Dual mTORC1/2 and HER2 blockade results in antitumor activity in
  preclinical models of breast cancer resistant to anti-HER2 therapy.}
\newblock Clinical cancer research : an official journal of the American
  Association for Cancer Research.  2012 May; 18(9):2603--2612.

\bibitem[{Chresta et~al.(2010)Chresta, Christine M and Davies, Barry R and
  Hickson, Ian and Harding, Tom and Cosulich, Sabina and Critchlow, Susan E and
  Vincent, John P and Ellston, Rebecca and Jones, Darren and Sini, Patrizia and
  James, Dominic and Howard, Zoe and Dudley, Phillippa and Hughes, Gareth and
  Smith, Lisa and Maguire, Sharon and Hummersone, Marc and Malagu, Karine and
  Menear, Keith and Jenkins, Richard and Jacobsen, Matt and Smith, Graeme C M
  and Guichard, Sylvie and Pass, Martin}]{Chresta:2010ir}
\textbf{\color{eLifeMediumGrey} Chresta CM}, Davies BR, Hickson I, Harding T,
  Cosulich S, Critchlow SE, Vincent JP, Ellston R, Jones D, Sini P, James D,
  Howard Z, Dudley P, Hughes G, Smith L, Maguire S, Hummersone M, Malagu K,
  Menear K, Jenkins R, et~al.
\newblock {AZD8055 is a potent, selective, and orally bioavailable
  ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro
  and in vivo antitumor activity.}
\newblock Cancer research.  2010 Jan; 70(1):288--298.

\bibitem[{Mallon et~al.(2011)Mallon, Robert and Feldberg, Larry R and Lucas,
  Judy and Chaudhary, Inder and Dehnhardt, Christoph and Santos, Efren Delos
  and Chen, Zecheng and dos Santos, Osvaldo and Ayral-Kaloustian, Semiramis and
  Venkatesan, Aranapakam and Hollander, Irwin}]{Mallon:2011gn}
\textbf{\color{eLifeMediumGrey} Mallon R}, Feldberg LR, Lucas J, Chaudhary I,
  Dehnhardt C, Santos ED, Chen Z, dos Santos O, Ayral-Kaloustian S, Venkatesan
  A, Hollander I.
\newblock {Antitumor efficacy of PKI-587, a highly potent dual PI3K/mTOR kinase
  inhibitor.}
\newblock Clinical cancer research : an official journal of the American
  Association for Cancer Research.  2011 May; 17(10):3193--3203.

\bibitem[{Mukherjee et~al.(2012)Mukherjee, Bipasha and Tomimatsu, Nozomi and
  Amancherla, Kaushik and Camacho, Cristel V and Pichamoorthy, Nandini and
  Burma, Sandeep}]{Mukherjee:2012ki}
\textbf{\color{eLifeMediumGrey} Mukherjee B}, Tomimatsu N, Amancherla K,
  Camacho CV, Pichamoorthy N, Burma S.
\newblock {The Dual PI3K/mTOR Inhibitor NVP-BEZ235 Is a Potent Inhibitor of
  ATM- and DNA-PKCs-Mediated DNA Damage Responses}.
\newblock Neoplasia.  2012 Jan; 14(1):34--IN8.

\bibitem[{Pongas and Fojo(2016)Pongas, Georgios and Fojo, Tito}]{Pongas:2016jm}
\textbf{\color{eLifeMediumGrey} Pongas G}, Fojo T.
\newblock {BEZ235: When Promising Science Meets Clinical Reality.}
\newblock The oncologist.  2016 Sep; 21(9):1033--1034.

\bibitem[{Eichhorn et~al.(2008)Eichhorn, Pieter J A and Gili, Mag{\"u}i and
  Scaltriti, Maurizio and Serra, Violeta and Guzman, Marta and Nijkamp, Wouter
  and Beijersbergen, Roderick L and Valero, Vanesa and Seoane, Joan and
  Bernards, Ren{\'e} and Baselga, Jos{\'e}}]{Eichhorn:2008ff}
\textbf{\color{eLifeMediumGrey} Eichhorn PJA}, Gili M, Scaltriti M, Serra V,
  Guzman M, Nijkamp W, Beijersbergen RL, Valero V, Seoane J, Bernards R,
  Baselga J.
\newblock {Phosphatidylinositol 3-kinase hyperactivation results in lapatinib
  resistance that is reversed by the mTOR/phosphatidylinositol 3-kinase
  inhibitor NVP-BEZ235.}
\newblock Cancer research.  2008 Nov; 68(22):9221--9230.

\bibitem[{Rodrik-Outmezguine et~al.(2011)Rodrik-Outmezguine, Vanessa S and
  Chandarlapaty, Sarat and Pagano, Nen C and Poulikakos, Poulikos I and
  Scaltriti, Maurizio and Moskatel, Elizabeth and Baselga, Jose and Guichard,
  Sylvie and Rosen, Neal}]{RodrikOutmezguine:2011fb}
\textbf{\color{eLifeMediumGrey} Rodrik-Outmezguine VS}, Chandarlapaty S, Pagano
  NC, Poulikakos PI, Scaltriti M, Moskatel E, Baselga J, Guichard S, Rosen N.
\newblock {mTOR kinase inhibition causes feedback-dependent biphasic regulation
  of AKT signaling.}
\newblock Cancer discovery.  2011 Aug; 1(3):248--259.

\bibitem[{Fan et~al.(2006)Fan, Qi-Wen and Knight, Zachary A and Goldenberg,
  David D and Yu, Wei and Mostov, Keith E and Stokoe, David and Shokat, Kevan M
  and Weiss, William A}]{Fan:2006kw}
\textbf{\color{eLifeMediumGrey} Fan QW}, Knight ZA, Goldenberg DD, Yu W, Mostov
  KE, Stokoe D, Shokat KM, Weiss WA.
\newblock {A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in
  glioma.}
\newblock Cancer Cell.  2006 May; 9(5):341--349.

\bibitem[{Wagle et~al.(2014)Wagle, Nikhil and Grabiner, Brian C and Van Allen,
  Eliezer M and Hodis, Eran and Jacobus, Susanna and Supko, Jeffrey G and
  Stewart, Michelle and Choueiri, Toni K and Gandhi, Leena and Cleary, James M
  and Elfiky, Aymen A and Taplin, Mary Ellen and Stack, Edward C and
  Signoretti, Sabina and Loda, Massimo and Shapiro, Geoffrey I and Sabatini,
  David M and Lander, Eric S and Gabriel, Stacey B and Kantoff, Philip W and
  Garraway, Levi A and Rosenberg, Jonathan E}]{Wagle:2014ej}
\textbf{\color{eLifeMediumGrey} Wagle N}, Grabiner BC, Van~Allen EM, Hodis E,
  Jacobus S, Supko JG, Stewart M, Choueiri TK, Gandhi L, Cleary JM, Elfiky AA,
  Taplin ME, Stack EC, Signoretti S, Loda M, Shapiro GI, Sabatini DM, Lander
  ES, Gabriel SB, Kantoff PW, et~al.
\newblock {Activating mTOR mutations in a patient with an extraordinary
  response on a phase I trial of everolimus and pazopanib.}
\newblock Cancer discovery.  2014 May; 4(5):546--553.

\bibitem[{{Wagle, Nikhil} et~al.(2014){Wagle, Nikhil} and {Grabiner, Brian C}
  and {Van Allen, Eliezer M} and {Amin-Mansour, Ali} and {Taylor-Weiner, Amaro}
  and {Rosenberg, Mara} and {Gray, Nathanael} and {Barletta, Justine A} and
  {Guo, Yanan} and {Swanson, Scott J} and {Ruan, Daniel T} and {Hanna, Glenn J}
  and {Haddad, Robert I} and {Getz, Gad} and {Kwiatkowski, David J} and
  {Carter, Scott L} and {Sabatini, David M} and {J{\"a}nne, Pasi A} and
  {Garraway, Levi A} and {Lorch, Jochen H}}]{Wagle:2014be}
\textbf{\color{eLifeMediumGrey} {Wagle, Nikhil}}, {Grabiner, Brian C}, {Van
  Allen, Eliezer M}, {Amin-Mansour, Ali}, {Taylor-Weiner, Amaro}, {Rosenberg,
  Mara}, {Gray, Nathanael}, {Barletta, Justine A}, {Guo, Yanan}, {Swanson,
  Scott J}, {Ruan, Daniel T}, {Hanna, Glenn J}, {Haddad, Robert I}, {Getz,
  Gad}, {Kwiatkowski, David J}, {Carter, Scott L}, {Sabatini, David M},
  {J{\"a}nne, Pasi A}, {Garraway, Levi A}, {Lorch, Jochen H}.
\newblock {Response and acquired resistance to everolimus in anaplastic thyroid
  cancer.}
\newblock The New England journal of medicine.  2014 Oct; 371(15):1426--1433.

\bibitem[{Rodrik-Outmezguine et~al.(2016)Rodrik-Outmezguine, Vanessa S and
  Okaniwa, Masanori and Yao, Zhan and Novotny, Chris J and McWhirter, Claire
  and Banaji, Arpitha and Won, Helen and Wong, Wai and Berger, Mike and de
  Stanchina, Elisa and Barratt, Derek G and Cosulich, Sabina and Klinowska,
  Teresa and Rosen, Neal and Shokat, Kevan M}]{RodrikOutmezguine:2016km}
\textbf{\color{eLifeMediumGrey} Rodrik-Outmezguine VS}, Okaniwa M, Yao Z,
  Novotny CJ, McWhirter C, Banaji A, Won H, Wong W, Berger M, de~Stanchina E,
  Barratt DG, Cosulich S, Klinowska T, Rosen N, Shokat KM.
\newblock {Overcoming mTOR resistance mutations with a new-generation mTOR
  inhibitor.}
\newblock Nature.  2016 Jun; 534(7606):272--276.

\bibitem[{Fan et~al.(2017)Fan, QiWen and Aksoy, Ozlem and Wong, Robyn A and
  Ilkhanizadeh, Shirin and Novotny, Chris J and Gustafson, William C and
  Truong, Albert Yi-Que and Cayanan, Geraldine and Simonds, Erin F and
  Haas-Kogan, Daphne and Phillips, Joanna J and Nicolaides, Theodore and
  Okaniwa, Masanori and Shokat, Kevan M and Weiss, William A}]{Fan:2017fk}
\textbf{\color{eLifeMediumGrey} Fan Q}, Aksoy O, Wong RA, Ilkhanizadeh S,
  Novotny CJ, Gustafson WC, Truong AYQ, Cayanan G, Simonds EF, Haas-Kogan D,
  Phillips JJ, Nicolaides T, Okaniwa M, Shokat KM, Weiss WA.
\newblock {A Kinase Inhibitor Targeted to mTORC1 Drives Regression in
  Glioblastoma.}
\newblock Cancer Cell.  2017 Mar; 31(3):424--435.

\bibitem[{Guertin and Sabatini(2007)Guertin, David A and Sabatini, David
  M}]{Guertin:2007dw}
\textbf{\color{eLifeMediumGrey} Guertin DA}, Sabatini DM.
\newblock {Defining the role of mTOR in cancer.}
\newblock Cancer Cell.  2007 Jul; 12(1):9--22.

\bibitem[{Grabiner et~al.(2014)Grabiner, Brian C and Nardi, Valentina and
  Birsoy, K{\i}vanc and Possemato, Richard and Shen, Kuang and Sinha, Sumi and
  Jordan, Alexander and Beck, Andrew H and Sabatini, David M}]{Grabiner:2014be}
\textbf{\color{eLifeMediumGrey} Grabiner BC}, Nardi V, Birsoy K, Possemato R,
  Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM.
\newblock {A diverse array of cancer-associated MTOR mutations are
  hyperactivating and can predict rapamycin sensitivity.}
\newblock Cancer discovery.  2014 May; 4(5):554--563.

\bibitem[{{Cancer Genome Atlas Research
  Network}(2013)}]{CancerGenomeAtlasResearchNetwork:2013ib}
\textbf{\color{eLifeMediumGrey} {Cancer Genome Atlas Research Network}}.
\newblock {Comprehensive molecular characterization of clear cell renal cell
  carcinoma.}
\newblock Nature.  2013 Jul; 499(7456):43--49.

\bibitem[{Xu et~al.(2016)Xu, Jianing and Pham, Can G and Albanese, Steven K and
  Dong, Yiyu and Oyama, Toshinao and Lee, Chung-Han and Rodrik-Outmezguine,
  Vanessa and Yao, Zhan and Han, Song and Chen, David and Parton, Daniel L and
  Chodera, John D and Rosen, Neal and Cheng, Emily H and Hsieh, James
  J}]{Xu:2016fw}
\textbf{\color{eLifeMediumGrey} Xu J}, Pham CG, Albanese SK, Dong Y, Oyama T,
  Lee CH, Rodrik-Outmezguine V, Yao Z, Han S, Chen D, Parton DL, Chodera JD,
  Rosen N, Cheng EH, Hsieh JJ.
\newblock {Mechanistically distinct cancer-associated mTOR activation clusters
  predict sensitivity to rapamycin.}
\newblock The Journal of clinical investigation.  2016 Sep; 126(9):3526--3540.

\bibitem[{Salsbury(2010)Salsbury, Freddie R}]{Salsbury:2010ij}
\textbf{\color{eLifeMediumGrey} Salsbury FR}.
\newblock {Molecular dynamics simulations of protein dynamics and their
  relevance to drug discovery.}
\newblock Current opinion in pharmacology.  2010 Dec; 10(6):738--744.

\bibitem[{{Shirts, M} and {Pande, V S}(2000)}]{Shirts:2000du}
\textbf{\color{eLifeMediumGrey} {Shirts, M}}, {Pande, V S}.
\newblock {COMPUTING: Screen Savers of the World Unite!}
\newblock Science.  2000 Dec; 290(5498):1903--1904.

\bibitem[{Shan et~al.(2012)Shan, Yibing and Eastwood, Michael P and Zhang,
  Xuewu and Kim, Eric T and Arkhipov, Anton and Dror, Ron O and Jumper, John
  and Kuriyan, John and Shaw, David E}]{Shan:2012bs}
\textbf{\color{eLifeMediumGrey} Shan Y}, Eastwood MP, Zhang X, Kim ET, Arkhipov
  A, Dror RO, Jumper J, Kuriyan J, Shaw DE.
\newblock {Oncogenic mutations counteract intrinsic disorder in the EGFR kinase
  and promote receptor dimerization.}
\newblock Cell.  2012 May; 149(4):860--870.

\bibitem[{Sutto and Gervasio(2013)Sutto, Ludovico and Gervasio, Francesco
  Luigi}]{Sutto:2013gy}
\textbf{\color{eLifeMediumGrey} Sutto L}, Gervasio FL.
\newblock {Effects of oncogenic mutations on the conformational free-energy
  landscape of EGFR kinase.}
\newblock Proceedings of the National Academy of Sciences of the United States
  of America.  2013 Jun; 110(26):10616--10621.

\bibitem[{Demir et~al.(2011)Demir, {\"O}zlem and Baronio, Roberta and Salehi,
  Faezeh and Wassman, Christopher D and Hall, Linda and Hatfield, G Wesley and
  Chamberlin, Richard and Kaiser, Peter and Lathrop, Richard H and Amaro,
  Rommie E}]{Demir:2011bc}
\textbf{\color{eLifeMediumGrey} Demir {\"O}}, Baronio R, Salehi F, Wassman CD,
  Hall L, Hatfield GW, Chamberlin R, Kaiser P, Lathrop RH, Amaro RE.
\newblock {Ensemble-based computational approach discriminates functional
  activity of p53 cancer and rescue mutants.}
\newblock PLoS Computational Biology.  2011 Oct; 7(10):e1002238.

\bibitem[{Witham et~al.(2011)Witham, Shawn and Takano, Kyoko and Schwartz,
  Charles and Alexov, Emil}]{Witham:2011co}
\textbf{\color{eLifeMediumGrey} Witham S}, Takano K, Schwartz C, Alexov E.
\newblock {A missense mutation in CLIC2 associated with intellectual disability
  is predicted by in silico modeling to affect protein stability and dynamics.}
\newblock Proteins.  2011 Aug; 79(8):2444--2454.

\bibitem[{Tsukamoto and Farrens(2013)Tsukamoto, Hisao and Farrens, David
  L}]{Tsukamoto:2013gr}
\textbf{\color{eLifeMediumGrey} Tsukamoto H}, Farrens DL.
\newblock {A constitutively activating mutation alters the dynamics and
  energetics of a key conformational change in a ligand-free G protein-coupled
  receptor.}
\newblock The Journal of biological chemistry.  2013 Sep; 288(39):28207--28216.

\bibitem[{Stehr et~al.(2011)Stehr, Henning and Jang, Seon-Hi J and Duarte,
  Jos{\'e} M and Wierling, Christoph and Lehrach, Hans and Lappe, Michael and
  Lange, Bodo M H}]{Stehr:2011ga}
\textbf{\color{eLifeMediumGrey} Stehr H}, Jang SHJ, Duarte JM, Wierling C,
  Lehrach H, Lappe M, Lange BMH.
\newblock {The structural impact of cancer-associated missense mutations in
  oncogenes and tumor suppressors.}
\newblock Molecular cancer.  2011 May; 10(1):54.

\bibitem[{Chodera et~al.(2011{\natexlab{b}})Chodera, John D and Mobley, David L
  and Shirts, Michael R and Dixon, Richard W and Branson, Kim and Pande, Vijay
  S}]{Chodera:Curr.Opin.Struct.Biol.:2011}
\textbf{\color{eLifeMediumGrey} Chodera JD}, Mobley DL, Shirts MR, Dixon RW,
  Branson K, Pande VS.
\newblock Alchemical Free Energy Methods for Drug Discovery: Progress and
  Challenges.
\newblock Curr Opin Struct Biol.  2011 Apr; 21(2):150--160.
\newblock \href{10.1016/j.sbi.2011.01.011}{\doiprefix
  \detokenize{10.1016/j.sbi.2011.01.011}}.

\bibitem[{Parton et~al.(2016)Parton, Daniel L and Grinaway, Patrick B and
  Hanson, Sonya M and Beauchamp, Kyle A and Chodera, John D}]{Parton:2016cc}
\textbf{\color{eLifeMediumGrey} Parton DL}, Grinaway PB, Hanson SM, Beauchamp
  KA, Chodera JD.
\newblock {Ensembler: Enabling High-Throughput Molecular Simulations at the
  Superfamily Scale.}
\newblock PLoS computational biology.  2016 Jun; 12(6):e1004728.

\bibitem[{Lindorff-Larsen et~al.(2010)Lindorff-Larsen, Kresten and Piana,
  Stefano and Palmo, Kim and Maragakis, Paul and Klepeis, John L and Dror, Ron
  O and Shaw, David E}]{LindorffLarsen:2010ei}
\textbf{\color{eLifeMediumGrey} Lindorff-Larsen K}, Piana S, Palmo K, Maragakis
  P, Klepeis JL, Dror RO, Shaw DE.
\newblock {Improved side-chain torsion potentials for the Amber ff99SB protein
  force field.}
\newblock Proteins.  2010 Jun; 78(8):1950--1958.

\bibitem[{{Jorgensen, William L} et~al.(1998){Jorgensen, William L} and
  {Chandrasekhar, Jayaraman} and {Madura, Jeffry D} and {Impey, Roger W} and
  {Klein, Michael L}}]{Jorgensen:1998fl}
\textbf{\color{eLifeMediumGrey} {Jorgensen, William L}}, {Chandrasekhar,
  Jayaraman}, {Madura, Jeffry D}, {Impey, Roger W}, {Klein, Michael L}.
\newblock {Comparison of simple potential functions for simulating liquid
  water}.
\newblock The Journal of chemical physics.  1998 Aug; 79(2):926--935.

\bibitem[{{Eastman, Peter} et~al.(2017){Eastman, Peter} and {Swails, Jason} and
  {Chodera, John D} and {McGibbon, Robert T} and {Zhao, Yutong} and {Beauchamp,
  Kyle A} and {Wang, Lee-Ping} and {Simmonett, Andrew C} and {Harrigan, Matthew
  P} and {Stern, Chaya D} and {Wiewiora, Rafal P} and {Brooks, Bernard R} and
  {Pande, Vijay S}}]{Eastman:2017kn}
\textbf{\color{eLifeMediumGrey} {Eastman, Peter}}, {Swails, Jason}, {Chodera,
  John D}, {McGibbon, Robert T}, {Zhao, Yutong}, {Beauchamp, Kyle A}, {Wang,
  Lee-Ping}, {Simmonett, Andrew C}, {Harrigan, Matthew P}, {Stern, Chaya D},
  {Wiewiora, Rafal P}, {Brooks, Bernard R}, {Pande, Vijay S}.
\newblock {OpenMM 7: Rapid development of high performance algorithms for
  molecular dynamics.}
\newblock PLoS Computational Biology.  2017 Jul; 13(7):e1005659.

\bibitem[{Eastman and Pande(2010)Eastman, Peter and Pande, Vijay
  S}]{Eastman:2010hq}
\textbf{\color{eLifeMediumGrey} Eastman P}, Pande VS.
\newblock {CCMA: A Robust, Parallelizable Constraint Method for Molecular
  Simulations.}
\newblock Journal of chemical theory and computation.  2010 Feb; 6(2):434--437.

\bibitem[{Miyamoto and Kollman(1992)Miyamoto, Shuichi and Kollman, Peter
  A}]{Miyamoto:1992fx}
\textbf{\color{eLifeMediumGrey} Miyamoto S}, Kollman PA.
\newblock {Settle: An analytical version of the SHAKE and RATTLE algorithm for
  rigid water models}.
\newblock Journal of Computational Chemistry.  1992; 13(8):952--962.

\bibitem[{Eastman et~al.(2013)Eastman, Peter and Friedrichs, Mark S and
  Chodera, John D and Radmer, Randall J and Bruns, Christopher M and Ku, Joy P
  and Beauchamp, Kyle A and Lane, Thomas J and Wang, Lee-Ping and Shukla,
  Diwakar and Tye, Tony and Houston, Mike and Stich, Timo and Klein, Christoph
  and Shirts, Michael R and Pande, Vijay S}]{Eastman:2013bo}
\textbf{\color{eLifeMediumGrey} Eastman P}, Friedrichs MS, Chodera JD, Radmer
  RJ, Bruns CM, Ku JP, Beauchamp KA, Lane TJ, Wang LP, Shukla D, Tye T, Houston
  M, Stich T, Klein C, Shirts MR, Pande VS.
\newblock {OpenMM 4: A Reusable, Extensible, Hardware Independent Library for
  High Performance Molecular Simulation.}
\newblock Journal of Chemical Theory and Computation.  2013 Jan; 9(1):461--469.

\bibitem[{{McGibbon, Robert T} et~al.(2015){McGibbon, Robert T} and {Beauchamp,
  Kyle A} and {Harrigan, Matthew P} and {Klein, Christoph} and {Swails, Jason
  M} and {Hern{\'a}ndez, Carlos X} and {Schwantes, Christian R} and {Wang,
  Lee-Ping} and {Lane, Thomas J} and {Pande, Vijay S}}]{McGibbon:2015fv}
\textbf{\color{eLifeMediumGrey} {McGibbon, Robert T}}, {Beauchamp, Kyle A},
  {Harrigan, Matthew P}, {Klein, Christoph}, {Swails, Jason M}, {Hern{\'a}ndez,
  Carlos X}, {Schwantes, Christian R}, {Wang, Lee-Ping}, {Lane, Thomas J},
  {Pande, Vijay S}.
\newblock {MDTraj: A Modern Open Library for the Analysis of Molecular Dynamics
  Trajectories.}
\newblock Biophysical journal.  2015 Oct; 109(8):1528--1532.

\bibitem[{Friesner et~al.(2004)Friesner, Richard A and Banks, Jay L and Murphy,
  Robert B and Halgren, Thomas A and Klicic, Jasna J and Mainz, Daniel T and
  Repasky, Matthew P and Knoll, Eric H and Shelley, Mee and Perry, Jason K and
  Shaw, David E and Francis, Perry and Shenkin, Peter S}]{Friesner:2004hm}
\textbf{\color{eLifeMediumGrey} Friesner RA}, Banks JL, Murphy RB, Halgren TA,
  Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE,
  Francis P, Shenkin PS.
\newblock {Glide: a new approach for rapid, accurate docking and scoring. 1.
  Method and assessment of docking accuracy.}
\newblock Journal of medicinal chemistry.  2004 Mar; 47(7):1739--1749.

\bibitem[{Halgren et~al.(2004)Halgren, Thomas A and Murphy, Robert B and
  Friesner, Richard A and Beard, Hege S and Frye, Leah L and Pollard, W Thomas
  and Banks, Jay L}]{Halgren:2004dr}
\textbf{\color{eLifeMediumGrey} Halgren TA}, Murphy RB, Friesner RA, Beard HS,
  Frye LL, Pollard WT, Banks JL.
\newblock {Glide: a new approach for rapid, accurate docking and scoring. 2.
  Enrichment factors in database screening.}
\newblock Journal of medicinal chemistry.  2004 Mar; 47(7):1750--1759.

\bibitem[{Friesner et~al.(2006)Friesner, Richard A and Murphy, Robert B and
  Repasky, Matthew P and Frye, Leah L and Greenwood, Jeremy R and Halgren,
  Thomas A and Sanschagrin, Paul C and Mainz, Daniel T}]{Friesner:2006cp}
\textbf{\color{eLifeMediumGrey} Friesner RA}, Murphy RB, Repasky MP, Frye LL,
  Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT.
\newblock {Extra precision glide: docking and scoring incorporating a model of
  hydrophobic enclosure for protein-ligand complexes.}
\newblock Journal of medicinal chemistry.  2006 Oct; 49(21):6177--6196.

\bibitem[{Wang et~al.(2015{\natexlab{b}})Wang, Lingle and Wu, Yujie and Deng,
  Yuqing and Kim, Byungchan and Pierce, Levi and Krilov, Goran and Lupyan,
  Dmitry and Robinson, Shaughnessy and Dahlgren, Markus K and Greenwood, Jeremy
  and Romero, Donna L and Masse, Craig and Knight, Jennifer L and Steinbrecher,
  Thomas and Beuming, Thijs and Damm, Wolfgang and Harder, Ed and Sherman,
  Woody and Brewer, Mark and Wester, Ron and Murcko, Mark and Frye, Leah and
  Farid, Ramy and Lin, Teng and Mobley, David L and Jorgensen, William L and
  Berne, Bruce J and Friesner, Richard A and Abel, Robert}]{Wang2015-cn}
\textbf{\color{eLifeMediumGrey} Wang L}, Wu Y, Deng Y, Kim B, Pierce L, Krilov
  G, Lupyan D, Robinson S, Dahlgren MK, Greenwood J, Romero DL, Masse C, Knight
  JL, Steinbrecher T, Beuming T, Damm W, Harder E, Sherman W, Brewer M, Wester
  R, et~al.
\newblock Accurate and Reliable Prediction of Relative Ligand Binding Potency
  in Prospective Drug Discovery by Way of a Modern {Free-Energy} Calculation
  Protocol and Force Field.
\newblock J Am Chem Soc.  2015 Feb; 137(7):2695--2703.

\bibitem[{Berendsen et~al.(1981)Berendsen, H J C and Postma, J P M and van
  Gunsteren, W F and Hermans, J}]{Berendsen:1981cq}
\textbf{\color{eLifeMediumGrey} Berendsen HJC}, Postma JPM, van Gunsteren WF,
  Hermans J.
\newblock {Interaction Models for Water in Relation to Protein Hydration}.
\newblock In: \emph{Intermolecular Forces} Dordrecht: Springer, Dordrecht;
  1981.p. 331--342.

\bibitem[{Bennett(1976)Bennett, Charles H}]{Bennett:1976gj}
\textbf{\color{eLifeMediumGrey} Bennett CH}.
\newblock {Efficient estimation of free energy differences from Monte Carlo
  data}.
\newblock Journal of Computational Physics.  1976 Oct; 22(2):245--268.

\bibitem[{Shirts et~al.(2003)Shirts, Michael R and Bair, Eric and Hooker, Giles
  and Pande, Vijay S}]{Shirts:2003cf}
\textbf{\color{eLifeMediumGrey} Shirts MR}, Bair E, Hooker G, Pande VS.
\newblock {Equilibrium Free Energies from Nonequilibrium Measurements Using
  Maximum-Likelihood Methods}.
\newblock Physical Review Letters.  2003; 91(14).

\bibitem[{Shukla et~al.(2014)Shukla, Diwakar and Meng, Yilin and Roux,
  Beno{\^\i}t and Pande, Vijay S}]{Shukla:2014jp}
\textbf{\color{eLifeMediumGrey} Shukla D}, Meng Y, Roux B, Pande VS.
\newblock {Activation pathway of Src kinase reveals intermediate states as
  targets for drug design.}
\newblock Nature communications.  2014; 5:3397.

\bibitem[{Jura et~al.(2011)Jura, Natalia and Zhang, Xuewu and Endres, Nicholas
  F and Seeliger, Markus A and Schindler, Thomas and Kuriyan,
  John}]{Jura:2011eh}
\textbf{\color{eLifeMediumGrey} Jura N}, Zhang X, Endres NF, Seeliger MA,
  Schindler T, Kuriyan J.
\newblock {Catalytic Control in the EGF Receptor and Its Connection to General
  Kinase Regulatory Mechanisms}.
\newblock Molecular cell.  2011 Apr; 42(1):9--22.

\bibitem[{Urano et~al.(2007)Urano, Jun and Sato, Tatsuhiro and Matsuo, Tomohiko
  and Otsubo, Yoko and Yamamoto, Masayuki and Tamanoi, Fuyuhiko}]{Urano:2007er}
\textbf{\color{eLifeMediumGrey} Urano J}, Sato T, Matsuo T, Otsubo Y, Yamamoto
  M, Tamanoi F.
\newblock {Point mutations in TOR confer Rheb-independent growth in fission
  yeast and nutrient-independent mammalian TOR signaling in mammalian cells.}
\newblock Proceedings of the National Academy of Sciences.  2007 Feb;
  104(9):3514--3519.

\bibitem[{Clark et~al.(2017)Clark, Anthony J and Gindin, Tatyana and Zhang,
  Baoshan and Wang, Lingle and Abel, Robert and Murret, Colleen S and Xu, Fang
  and Bao, Amy and Lu, Nina J and Zhou, Tongqing and others}]{clark2017free}
\textbf{\color{eLifeMediumGrey} Clark AJ}, Gindin T, Zhang B, Wang L, Abel R,
  Murret CS, Xu F, Bao A, Lu NJ, Zhou T, et~al.
\newblock Free Energy Perturbation Calculation of Relative Binding Free Energy
  between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1.
\newblock Journal of molecular biology.  2017; 429(7):930--947.

\bibitem[{Steinbrecher et~al.(2017)Steinbrecher, Thomas and Zhu, Chongkai and
  Wang, Lingle and Abel, Robert and Negron, Christopher and Pearlman, David and
  Feyfant, Eric and Duan, Jianxin and Sherman,
  Woody}]{steinbrecher2017predicting}
\textbf{\color{eLifeMediumGrey} Steinbrecher T}, Zhu C, Wang L, Abel R, Negron
  C, Pearlman D, Feyfant E, Duan J, Sherman W.
\newblock Predicting the Effect of Amino Acid Single-Point Mutations on Protein
  Stability—Large-Scale Validation of MD-Based Relative Free Energy
  Calculations.
\newblock Journal of molecular biology.  2017; 429(7):948--963.

\bibitem[{Zehir et~al.(2017{\natexlab{a}})Zehir, Ahmet and Benayed, Ryma and
  Shah, Ronak H and Syed, Aijazuddin and Middha, Sumit and Kim, Hyunjae R and
  Srinivasan, Preethi and Gao, Jianjiong and Chakravarty, Debyani and Devlin,
  Sean M and Hellmann, Matthew D and Barron, David A and Schram, Alison M and
  Hameed, Meera and Dogan, Snjezana and Ross, Dara S and Hechtman, Jaclyn F and
  DeLair, Deborah F and Yao, JinJuan and Mandelker, Diana L and Cheng, Donavan
  T and Chandramohan, Raghu and Mohanty, Abhinita S and Ptashkin, Ryan N and
  Jayakumaran, Gowtham and Prasad, Meera and Syed, Mustafa H and Rema, Anoop
  Balakrishnan and Liu, Zhen Y and Nafa, Khedoudja and Borsu, Laetitia and
  Sadowska, Justyna and Casanova, Jacklyn and Bacares, Ruben and Kiecka, Iwona
  J and Razumova, Anna and Son, Julie B and Stewart, Lisa and Baldi, Tessara
  and Mullaney, Kerry A and Al-Ahmadie, Hikmat and Vakiani, Efsevia and
  Abeshouse, Adam A and Penson, Alexander V and Jonsson, Philip and Camacho,
  Niedzica and Chang, Matthew T and Won, Helen H and Gross, Benjamin E and
  Kundra, Ritika and Heins, Zachary J and Chen, Hsiao-Wei and Phillips, Sarah
  and Zhang, Hongxin and Wang, Jiaojiao and Ochoa, Angelica and Wills, Jonathan
  and Eubank, Michael and Thomas, Stacy B and Gardos, Stuart M and Reales,
  Dalicia N and Galle, Jesse and Durany, Robert and Cambria, Roy and Abida,
  Wassim and Cercek, Andrea and Feldman, Darren R and Gounder, Mrinal M and
  Hakimi, A Ari and Harding, James J and Iyer, Gopa and Janjigian, Yelena Y and
  Jordan, Emmet J and Kelly, Ciara M and Lowery, Maeve A and Morris, Luc G T
  and Omuro, Antonio M and Raj, Nitya and Razavi, Pedram and Shoushtari,
  Alexander N and Shukla, Neerav and Soumerai, Tara E and Varghese, Anna M and
  Yaeger, Rona and Coleman, Jonathan and Bochner, Bernard and Riely, Gregory J
  and Saltz, Leonard B and Scher, Howard I and Sabbatini, Paul J and Robson,
  Mark E and Klimstra, David S and Taylor, Barry S and Baselga, Jose and
  Schultz, Nikolaus and Hyman, David M and Arcila, Maria E and Solit, David B
  and Ladanyi, Marc and Berger, Michael F}]{Zehir:Nat.Med.:2017}
\textbf{\color{eLifeMediumGrey} Zehir A}, Benayed R, Shah RH, Syed A, Middha S,
  Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron
  DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J,
  Mandelker DL, et~al.
\newblock Mutational Landscape of Metastatic Cancer Revealed from Prospective
  Clinical Sequencing of 10,000 Patients.
\newblock Nat Med.  2017 May; 23(6):703--713.
\newblock \href{10.1038/nm.4333}{\doiprefix \detokenize{10.1038/nm.4333}}.

\bibitem[{Cerami et~al.(2012{\natexlab{a}})Cerami, Ethan and Gao, Jianjiong and
  Dogrusoz, Ugur and Gross, Benjamin E and Sumer, Selcuk Onur and Aksoy,
  B{\"u}lent Arman and Jacobsen, Anders and Byrne, Caitlin J and Heuer, Michael
  L and Larsson, Erik and Antipin, Yevgeniy and Reva, Boris and Goldberg,
  Arthur P and Sander, Chris and Schultz, Nikolaus}]{Cerami:2012eu}
\textbf{\color{eLifeMediumGrey} Cerami E}, Gao J, Dogrusoz U, Gross BE, Sumer
  SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B,
  Goldberg AP, Sander C, Schultz N.
\newblock {The cBio cancer genomics portal: an open platform for exploring
  multidimensional cancer genomics data.}
\newblock Cancer discovery.  2012 May; 2(5):401--404.

\bibitem[{Gao et~al.(2013)Gao, Jianjiong and Aksoy, B{\"u}lent Arman and
  Dogrusoz, Ugur and Dresdner, Gideon and Gross, Benjamin and Sumer, S Onur and
  Sun, Yichao and Jacobsen, Anders and Sinha, Rileen and Larsson, Erik and
  Cerami, Ethan and Sander, Chris and Schultz, Nikolaus}]{Gao:2013kd}
\textbf{\color{eLifeMediumGrey} Gao J}, Aksoy BA, Dogrusoz U, Dresdner G, Gross
  B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C,
  Schultz N.
\newblock {Integrative Analysis of Complex Cancer Genomics and Clinical
  Profiles Using the cBioPortal}.
\newblock Science signaling.  2013 Apr; 6(269):pl1--pl1.

\bibitem[{Barretina et~al.(2012)Barretina, Jordi and Caponigro, Giordano and
  Stransky, Nicolas and Venkatesan, Kavitha and Margolin, Adam A and Kim,
  Sungjoon and Wilson, Christopher J and Leh{\'a}r, Joseph and Kryukov, Gregory
  V and Sonkin, Dmitriy and Reddy, Anupama and Liu, Manway and Murray, Lauren
  and Berger, Michael F and Monahan, John E and Morais, Paula and Meltzer, Jodi
  and Korejwa, Adam and Jan{\'e}-Valbuena, Judit and Mapa, Felipa A and
  Thibault, Joseph and Bric-Furlong, Eva and Raman, Pichai and Shipway, Aaron
  and Engels, Ingo H and Cheng, Jill and Yu, Guoying K and Yu, Jianjun and
  Aspesi, Peter and de Silva, Melanie and Jagtap, Kalpana and Jones, Michael D
  and Wang, Li and Hatton, Charles and Palescandolo, Emanuele and Gupta,
  Supriya and Mahan, Scott and Sougnez, Carrie and Onofrio, Robert C and
  Liefeld, Ted and MacConaill, Laura and Winckler, Wendy and Reich, Michael and
  Li, Nanxin and Mesirov, Jill P and Gabriel, Stacey B and Getz, Gad and
  Ardlie, Kristin and Chan, Vivien and Myer, Vic E and Weber, Barbara L and
  Porter, Jeff and Warmuth, Markus and Finan, Peter and Harris, Jennifer L and
  Meyerson, Matthew and Golub, Todd R and Morrissey, Michael P and Sellers,
  William R and Schlegel, Robert and Garraway, Levi A}]{Barretina:2012fp}
\textbf{\color{eLifeMediumGrey} Barretina J}, Caponigro G, Stransky N,
  Venkatesan K, Margolin AA, Kim S, Wilson CJ, Leh{\'a}r J, Kryukov GV, Sonkin
  D, Reddy A, Liu M, Murray L, Berger MF, Monahan JE, Morais P, Meltzer J,
  Korejwa A, Jan{\'e}-Valbuena J, Mapa FA, et~al.
\newblock {The Cancer Cell Line Encyclopedia enables predictive modelling of
  anticancer drug sensitivity.}
\newblock Nature.  2012 Mar; 483(7391):603--607.

\bibitem[{{Cancer Genome Atlas Research Network} et~al.(2017){Cancer Genome
  Atlas Research Network} and {Analysis Working Group: Asan University} and {BC
  Cancer Agency} and {Brigham and Women{\textquoteright}s Hospital} and {Broad
  Institute} and {Brown University} and {Case Western Reserve University} and
  {Dana-Farber Cancer Institute} and {Duke University} and {Greater Poland
  Cancer Centre} and {Harvard Medical School} and {Institute for Systems
  Biology} and {KU Leuven} and {Mayo Clinic} and {Memorial Sloan Kettering
  Cancer Center} and {National Cancer Institute} and {Nationwide
  Children{\textquoteright}s Hospital} and {Stanford University} and
  {University of Alabama} and {University of Michigan} and {University of North
  Carolina} and {University of Pittsburgh} and {University of Rochester} and
  {University of Southern California} and {University of Texas MD Anderson
  Cancer Center} and {University of Washington} and {Van Andel Research
  Institute} and {Vanderbilt University} and {Washington University} and
  {Genome Sequencing Center: Broad Institute} and {Washington University in St.
  Louis} and {Genome Characterization Centers: BC Cancer Agency} and {Broad
  Institute} and {Harvard Medical School} and {Sidney Kimmel Comprehensive
  Cancer Center at Johns Hopkins University} and {University of North Carolina}
  and {University of Southern California Epigenome Center} and {University of
  Texas MD Anderson Cancer Center} and {Van Andel Research Institute} and
  {Genome Data Analysis Centers: Broad Institute} and {Brown University:} and
  {Harvard Medical School} and {Institute for Systems Biology} and {Memorial
  Sloan Kettering Cancer Center} and {University of California Santa Cruz} and
  {University of Texas MD Anderson Cancer Center} and {Biospecimen Core
  Resource: International Genomics Consortium} and {Research Institute at
  Nationwide Children{\textquoteright}s Hospital} and {Tissue Source Sites:
  Analytic Biologic Services} and {Asan Medical Center} and {Asterand
  Bioscience} and {Barretos Cancer Hospital} and {BioreclamationIVT} and
  {Botkin Municipal Clinic} and {Chonnam National University Medical School}
  and {Christiana Care Health System} and {Cureline} and {Duke University} and
  {Emory University} and {Erasmus University} and {Indiana University School of
  Medicine} and {Institute of Oncology of Moldova} and {International Genomics
  Consortium} and {Invidumed} and {Israelitisches Krankenhaus Hamburg} and
  {Keimyung University School of Medicine} and {Memorial Sloan Kettering Cancer
  Center} and {National Cancer Center Goyang} and {Ontario Tumour Bank} and
  {Peter MacCallum Cancer Centre} and {Pusan National University Medical
  School} and {Ribeir{\~a}o Preto Medical School} and {St.
  Joseph{\textquoteright}s Hospital {\&}Medical Center} and {St. Petersburg
  Academic University} and {Tayside Tissue Bank} and {University of Dundee} and
  {University of Kansas Medical Center} and {University of Michigan} and
  {University of North Carolina at Chapel Hill} and {University of Pittsburgh
  School of Medicine} and {University of Texas MD Anderson Cancer Center} and
  {Disease Working Group: Duke University} and {Memorial Sloan Kettering Cancer
  Center} and {National Cancer Institute} and {University of Texas MD Anderson
  Cancer Center} and {Yonsei University College of Medicine} and {Data
  Coordination Center: CSRA Inc.} and {Project Team: National Institutes of
  Health}}]{CancerGenomeAtlasResearchNetwork:2017fh}
\textbf{\color{eLifeMediumGrey} {Cancer Genome Atlas Research Network}},
  {Analysis Working Group: Asan University}, {BC Cancer Agency}, {Brigham and
  Women{\textquoteright}s Hospital}, {Broad Institute}, {Brown University},
  {Case Western Reserve University}, {Dana-Farber Cancer Institute}, {Duke
  University}, {Greater Poland Cancer Centre}, {Harvard Medical School},
  {Institute for Systems Biology}, {KU Leuven}, {Mayo Clinic}, {Memorial Sloan
  Kettering Cancer Center}, {National Cancer Institute}, {Nationwide
  Children{\textquoteright}s Hospital}, {Stanford University}, {University of
  Alabama}, {University of Michigan}, et~al.
\newblock {Integrated genomic characterization of oesophageal carcinoma.}
\newblock Nature.  2017 Jan; 541(7636):169--175.

\bibitem[{Stuttfeld et~al.(2018)Stuttfeld, Edward and Aylett, Christopher Hs
  and Imseng, Stefan and Boehringer, Daniel and Scaiola, Alain and Sauer,
  Evelyn and Hall, Michael N and Maier, Timm and Ban, Nenad}]{Stuttfeld:2018kg}
\textbf{\color{eLifeMediumGrey} Stuttfeld E}, Aylett CH, Imseng S, Boehringer
  D, Scaiola A, Sauer E, Hall MN, Maier T, Ban N.
\newblock {Architecture of the human mTORC2 core complex.}
\newblock eLife.  2018 Feb; 7:48.

\bibitem[{Yuan and Guan(2016)Yuan, Hai-Xin and Guan, Kun-Liang}]{Yuan:2016ef}
\textbf{\color{eLifeMediumGrey} Yuan HX}, Guan KL.
\newblock {Structural insights of mTOR complex 1.}
\newblock Cell research.  2016 Mar; 26(3):267--268.

\bibitem[{Yang et~al.(2016)Yang, Huirong and Wang, Jia and Liu, Mengjie and
  Chen, Xizi and Huang, Min and Tan, Dan and Dong, Meng-Qiu and Wong, Catherine
  C L and Wang, Jiawei and Xu, Yanhui and Wang, Hong-Wei}]{Yang:2016kk}
\textbf{\color{eLifeMediumGrey} Yang H}, Wang J, Liu M, Chen X, Huang M, Tan D,
  Dong MQ, Wong CCL, Wang J, Xu Y, Wang HW.
\newblock {4.4 {\AA} Resolution Cryo-EM structure of human mTOR Complex 1.}
\newblock Protein {\&} cell.  2016 Dec; 7(12):878--887.

\bibitem[{Manning et~al.(2002{\natexlab{c}})G. Manning and D. B. Whyte and R.
  Martinez and T. Hunter and S. Sudarsanam}]{manning:science:2002:kinome}
\textbf{\color{eLifeMediumGrey} Manning G}, Whyte DB, Martinez R, Hunter T,
  Sudarsanam S.
\newblock The protein kinase complement of the human genome.
\newblock Science.  2002; 298:1912--1934.

\bibitem[{Hunter and Manning(2015)Hunter, Tony and Manning,
  Gerard}]{Hunter:ReceptorTyrosineKinases:StructureFunctionsandRoleinHumanDisease:2015}
\textbf{\color{eLifeMediumGrey} Hunter T}, Manning G.
\newblock The {{Eukaryotic Protein Kinase Superfamily}} and the {{Emergence}}
  of {{Receptor Tyrosine Kinases}}.
\newblock In: Wheeler DL, Yarden Y, editors. \emph{Receptor {{Tyrosine
  Kinases}}: {{Structure}}, {{Functions}} and {{Role}} in {{Human Disease}}}
  New York, NY: {Springer New York}; 2015.p. 1--15.

\bibitem[{Knight et~al.(2010{\natexlab{b}})Knight, Zachary A. and Lin, Henry
  and Shokat, Kevan M.}]{knight_targeting_2010}
\textbf{\color{eLifeMediumGrey} Knight ZA}, Lin H, Shokat KM.
\newblock Targeting the cancer kinome through polypharmacology.
\newblock Nature Reviews Cancer.  2010 Feb; 10(2):130--137.
\newblock
  \urlprefix\url{http://www.nature.com.proxy.library.cornell.edu/nrc/journal/v10/n2/full/nrc2787.html},
  \href{10.1038/nrc2787}{\doiprefix \detokenize{10.1038/nrc2787}}.

\bibitem[{{American Cancer Society}(2015)}]{acs-cancer-facts-2015}
\textbf{\color{eLifeMediumGrey} {American Cancer Society}}, {Cancer Facts \&
  Figures 2015}.
\newblock American Cancer Society; 2015.

\bibitem[{Cohen and Tcherpakov(2010{\natexlab{b}})Cohen, Philip and Tcherpakov,
  Marianna}]{cohen_will_2010}
\textbf{\color{eLifeMediumGrey} Cohen P}, Tcherpakov M.
\newblock Will the {Ubiquitin} {System} {Furnish} as {Many} {Drug} {Targets} as
  {Protein} {Kinases}?
\newblock Cell.  2010 Nov; 143(5):686--693.
\newblock
  \urlprefix\url{http://linkinghub.elsevier.com/retrieve/pii/S0092867410012961},
  \href{10.1016/j.cell.2010.11.016}{\doiprefix
  \detokenize{10.1016/j.cell.2010.11.016}}.

\bibitem[{Stegmeier et~al.(2010)F. Stegmeier and M. Warmuth and W. R. Sellers
  and M. Dorsch}]{stegmeier:clpt:2010:imatinib-lessons}
\textbf{\color{eLifeMediumGrey} Stegmeier F}, Warmuth M, Sellers WR, Dorsch M.
\newblock Targeted cancer therapies in the twenty-first century: Lessons from
  imatinib.
\newblock Clin Pharm \& Therap.  2010; 87:543--552.
\newblock \href{10.1038/clpt.2009.297}{\doiprefix
  \detokenize{10.1038/clpt.2009.297}}.

\bibitem[{Wu et~al.(2015{\natexlab{b}})Wu, Peng and Nielsen, Thomas E. and
  Clausen, Mads H.}]{wu_fda-approved_2015}
\textbf{\color{eLifeMediumGrey} Wu P}, Nielsen TE, Clausen MH.
\newblock {FDA}-approved small-molecule kinase inhibitors.
\newblock Trends in Pharmacological Sciences.  2015 Jul; 36(7):422--439.
\newblock
  \urlprefix\url{http://linkinghub.elsevier.com/retrieve/pii/S0165614715000772},
  \href{10.1016/j.tips.2015.04.005}{\doiprefix
  \detokenize{10.1016/j.tips.2015.04.005}}.

\bibitem[{Volkamer et~al.(2015{\natexlab{b}})Volkamer, Andrea and Eid, Sameh
  and Turk, Samo and Jaeger, Sabrina and Rippmann, Friedrich and Fulle,
  Simone}]{doi:10.1021/ci500624s}
\textbf{\color{eLifeMediumGrey} Volkamer A}, Eid S, Turk S, Jaeger S, Rippmann
  F, Fulle S.
\newblock Pocketome of Human Kinases: Prioritizing the ATP Binding Sites of
  (Yet) Untapped Protein Kinases for Drug Discovery.
\newblock Journal of Chemical Information and Modeling.  2015; 55(3):538--549.
\newblock \urlprefix\url{http://dx.doi.org/10.1021/ci500624s},
  \href{10.1021/ci500624s}{\doiprefix \detokenize{10.1021/ci500624s}}, pMID:
  25557645.

\bibitem[{Chandarlapaty et~al.(2011{\natexlab{c}})Chandarlapaty, Sarat and
  Sawai, Ayana and Scaltriti, Maurizio and Rodrik-Outmezguine, Vanessa and
  Grbovic-Huezo, Olivera and Serra, Violeta and Majumder, Pradip K. and
  Baselga, Jose and Rosen, Neal}]{chandarlapaty_akt_2011}
\textbf{\color{eLifeMediumGrey} Chandarlapaty S}, Sawai A, Scaltriti M,
  Rodrik-Outmezguine V, Grbovic-Huezo O, Serra V, Majumder PK, Baselga J, Rosen
  N.
\newblock {AKT} {Inhibition} {Relieves} {Feedback} {Suppression} of {Receptor}
  {Tyrosine} {Kinase} {Expression} and {Activity}.
\newblock Cancer Cell.  2011 Jan; 19(1):58--71.
\newblock
  \urlprefix\url{http://linkinghub.elsevier.com/retrieve/pii/S1535610810004332},
  \href{10.1016/j.ccr.2010.10.031}{\doiprefix
  \detokenize{10.1016/j.ccr.2010.10.031}}.

\bibitem[{Jia et~al.(2016)Jia, Yong and Yun, Cai-Hong and Park, Eunyoung and
  Ercan, Dalia and Manuia, Mari and Juarez, Jose and Xu, Chunxiao and Rhee,
  Kevin and Chen, Ting and Zhang, Haikuo and Palakurthi, Sangeetha and Jang,
  Jaebong and Lelais, Gerald and DiDonato, Michael and Bursulaya, Badry and
  Michellys, Pierre-Yves and Epple, Robert and Marsilje, Thomas H and McNeill,
  Matthew and Lu, Wenshuo and Harris, Jennifer and Bender, Steven and Wong,
  Kwok-Kin and J{\"a}nne, Pasi A and Eck, Michael J}]{Jia:2016di}
\textbf{\color{eLifeMediumGrey} Jia Y}, Yun CH, Park E, Ercan D, Manuia M,
  Juarez J, Xu C, Rhee K, Chen T, Zhang H, Palakurthi S, Jang J, Lelais G,
  DiDonato M, Bursulaya B, Michellys PY, Epple R, Marsilje TH, McNeill M, Lu W,
  et~al.
\newblock {Overcoming EGFR(T790M) and EGFR(C797S) resistance with
  mutant-selective allosteric inhibitors}.
\newblock Nature.  2016 Jun; 534(7605):129--132.

\bibitem[{Politi et~al.(2015)Politi, Katerina and Ayeni, Deborah and Lynch,
  Thomas}]{Politi:2015fg}
\textbf{\color{eLifeMediumGrey} Politi K}, Ayeni D, Lynch T.
\newblock {The Next Wave of EGFR Tyrosine Kinase Inhibitors Enter the Clinic.}
\newblock Cancer Cell.  2015 Jun; 27(6):751--753.

\bibitem[{Karaman et~al.(2008)Mazen W. Karaman and Sanna Herrgard and Daniel K.
  Treiber and Paul Gallant and Corey E. Atteridge and Brian T. Campbell and
  Katrina W. Chan and Pietro Ciceri and Mindy I. Davis and Philip T. Edeen and
  Raffaella Faraoni and Mark Floyd and Jeremy P. Hunt and Daniel J. Lockhart
  and Zdravko V. Milanov and Michael J. Morrison and Gabriel Pallares and
  Hitesh K. Patel and Stephanie Pritchard and Lisa M. Wodicka and Patrick P.
  Zarrinkar}]{karaman:nature-biotech:2008:kinase-selectivity-map}
\textbf{\color{eLifeMediumGrey} Karaman MW}, Herrgard S, Treiber DK, Gallant P,
  Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, Faraoni R,
  Floyd M, Hunt JP, Lockhart DJ, Milanov ZV, Morrison MJ, Pallares G, Patel HK,
  Pritchard S, Wodicka LM, et~al.
\newblock A quantitative analysis of kinase inhibitor selectivity.
\newblock Nature Biotech.  2008; 26:127--132.

\bibitem[{Davis et~al.(2011{\natexlab{b}})Davis, Mindy I and Hunt, Jeremy P and
  Herrgard, Sanna and Ciceri, Pietro and Wodicka, Lisa M and Pallares, Gabriel
  and Hocker, Michael and Treiber, Daniel K and Zarrinkar, Patrick
  P}]{Davis:2011fz}
\textbf{\color{eLifeMediumGrey} Davis MI}, Hunt JP, Herrgard S, Ciceri P,
  Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP.
\newblock {Comprehensive analysis of kinase inhibitor selectivity.}
\newblock Nature biotechnology.  2011 Nov; 29(11):1046--1051.

\bibitem[{M{\'e}dard et~al.(2015)M{\'e}dard, Guillaume and Pachl, Fiona and
  Ruprecht, Benjamin and Klaeger, Susan and Heinzlmeir, Stephanie and Helm,
  Dominic and Qiao, Huichao and Ku, Xin and Wilhelm, Mathias and Kuehne, Thomas
  and Wu, Zhixiang and Dittmann, Antje and Hopf, Carsten and Kramer, Karl and
  Kuster, Bernhard}]{Medard:2015hv}
\textbf{\color{eLifeMediumGrey} M{\'e}dard G}, Pachl F, Ruprecht B, Klaeger S,
  Heinzlmeir S, Helm D, Qiao H, Ku X, Wilhelm M, Kuehne T, Wu Z, Dittmann A,
  Hopf C, Kramer K, Kuster B.
\newblock {Optimized chemical proteomics assay for kinase inhibitor profiling.}
\newblock Journal of proteome research.  2015 Mar; 14(3):1574--1586.

\bibitem[{Chambers et~al.(2004)Stephen P. Chambers and Douglas A. Austen and
  John R. Fulghum and Walter M. Kim}]{vertex:2004:kinase-expression}
\textbf{\color{eLifeMediumGrey} Chambers SP}, Austen DA, Fulghum JR, Kim WM.
\newblock High-throughput screening for soluble recombinant expressed kinases
  in \emph{Escherichia coli} and insect cells.
\newblock Protein Expression and Purification.  2004; 36:40--47.
\newblock \href{10.1016/j.pep.2004.03.003}{\doiprefix
  \detokenize{10.1016/j.pep.2004.03.003}}.

\bibitem[{Wang et~al.(2008)Leyu Wang and Meta Foster and Yan Zhang and Willian
  R. Tschantz and Lily Yang and Joe Worrall and Christie Loh and Xu
  Xu}]{wang:protein-express-pur:2008:high-yield-kinase-insect-cells}
\textbf{\color{eLifeMediumGrey} Wang L}, Foster M, Zhang Y, Tschantz WR, Yang
  L, Worrall J, Loh C, Xu X.
\newblock High yield expression of non-phosphorylated protein tyrosine kinases
  in insect cells.
\newblock Protein Express Pur.  2008; 61:204--211.
\newblock \href{10.1016/j.pep.2008.05.017}{\doiprefix
  \detokenize{10.1016/j.pep.2008.05.017}}.

\bibitem[{Seeliger et~al.(2005)Markus A. Seeliger and Matthew Young and M.
  Nidanie Henderson and Patricia Pellicena and David S. King and Arnold M.
  Falick and John Kuriyan}]{seeliger:2005:protein-sci:kinase-expression}
\textbf{\color{eLifeMediumGrey} Seeliger MA}, Young M, Henderson MN, Pellicena
  P, King DS, Falick AM, Kuriyan J.
\newblock High yield bacterial expression of active {c-Abl} and {c-Src}
  tyrosine kinases.
\newblock Protein Sci.  2005; 14:3135--3139.

\bibitem[{{The Structural Genomics Consortium}(2012)}]{sgc-kinome}
\textbf{\color{eLifeMediumGrey} {The Structural Genomics Consortium}}, {SGC:}
  Progress in protein kinase structural biology; 2012.
\newblock \urlprefix\url{http://www.thesgc.org/scientists/resources/kinases},
  updated 18 Jul 2012.

\bibitem[{Weisberg et~al.(2005)Weisberg, Ellen and Manley, Paul W and
  Breitenstein, Werner and Br{\"u}ggen, Josef and Cowan-Jacob, Sandra W and
  Ray, Arghya and Huntly, Brian and Fabbro, Doriano and Fendrich, Gabriele and
  Hall-Meyers, Elizabeth and Kung, Andrew L and Mestan, J{\"u}rgen and Daley,
  George Q and Callahan, Linda and Catley, Laurie and Cavazza, Cara and Azam,
  Mohammad and Mohammed, Azam and Neuberg, Donna and Wright, Renee D and
  Gilliland, D Gary and Griffin, James D}]{Weisberg:2005boa}
\textbf{\color{eLifeMediumGrey} Weisberg E}, Manley PW, Breitenstein W,
  Br{\"u}ggen J, Cowan-Jacob SW, Ray A, Huntly B, Fabbro D, Fendrich G,
  Hall-Meyers E, Kung AL, Mestan J, Daley GQ, Callahan L, Catley L, Cavazza C,
  Azam M, Mohammed A, Neuberg D, Wright RD, et~al.
\newblock {Characterization of AMN107, a selective inhibitor of native and
  mutant Bcr-Abl.}
\newblock Cancer Cell.  2005 Feb; 7(2):129--141.

\bibitem[{Levinson et~al.(2006)Nicholas M. Levinson and Olga Kuchment and Kui
  Shen and Matthew A. Young and Michael Koldobskly and Martin Karplus and
  Phillip A. Cole and John Kuriyan}]{levinson:plos-biology:2006:inactive-abl}
\textbf{\color{eLifeMediumGrey} Levinson NM}, Kuchment O, Shen K, Young MA,
  Koldobskly M, Karplus M, Cole PA, Kuriyan J.
\newblock A {Src}-like inactive conformation in the {Abl} tyrosine kinase
  domain.
\newblock Plos Biology.  2006; 4:e144.

\bibitem[{Horio et~al.(2007)Horio, T and Hamasaki, T and Inoue, T and Wakayama,
  T}]{Horio:2007wo}
\textbf{\color{eLifeMediumGrey} Horio T}, Hamasaki T, Inoue T, Wakayama T.
\newblock {Structural factors contributing to the Abl/Lyn dual inhibitory
  activity of 3-substituted benzamide derivatives}.
\newblock Bioorganic {\&} medicinal {\ldots}.  2007; .

\bibitem[{{UniProt Consortium}(2017)}]{uniprot:2017}
\textbf{\color{eLifeMediumGrey} {UniProt Consortium}}.
\newblock {UniProt}: The universal protein knowledgebase.
\newblock Nucl Acids Res.  2017; 45:D158--D169.
\newblock \href{10.1093/nar/gkh131}{\doiprefix
  \detokenize{10.1093/nar/gkh131}}.

\bibitem[{Puhl et~al.(2009)Puhl, Ana Cristina and Giacomini, Cecilia and
  Irazoqui, Gabriela and Batista Viera, Francisco and Villarino, Andrea and
  Terenzi, Hern{\'a}n}]{Puhl:2009gg}
\textbf{\color{eLifeMediumGrey} Puhl AC}, Giacomini C, Irazoqui G,
  Batista~Viera F, Villarino A, Terenzi H.
\newblock {Covalent immobilization of tobacco-etch-virus NIa protease: a useful
  tool for cleavage of the histidine tag of recombinant proteins}.
\newblock Biotechnology and Applied Biochemistry.  2009 May; 53(3):165--174.

\bibitem[{Nallamsetty et~al.(2004)Nallamsetty, Sreedevi and Kapust, Rachel B
  and T{\"o}zs{\'e}r, J{\'o}zsef and Cherry, Scott and Tropea, Joseph E and
  Copeland, Terry D and Waugh, David S}]{Nallamsetty:2004cp}
\textbf{\color{eLifeMediumGrey} Nallamsetty S}, Kapust RB, T{\"o}zs{\'e}r J,
  Cherry S, Tropea JE, Copeland TD, Waugh DS.
\newblock {Efficient site-specific processing of fusion proteins by tobacco
  vein mottling virus protease in vivo and in vitro.}
\newblock Protein expression and purification.  2004 Nov; 38(1):108--115.

\bibitem[{Sun et~al.(2012)Sun, Changsheng and Liang, Jiongqiu and Shi, Rui and
  Gao, Xuna and Zhang, Ruijuan and Hong, Fulin and Yuan, Qihang and Wang,
  Shengbin}]{Sun:2012bh}
\textbf{\color{eLifeMediumGrey} Sun C}, Liang J, Shi R, Gao X, Zhang R, Hong F,
  Yuan Q, Wang S.
\newblock {Tobacco etch virus protease retains its activity in various buffers
  and in the presence of diverse additives}.
\newblock Protein expression and purification.  2012 Mar; 82(1):226--231.

\bibitem[{Lo et~al.(2004)Lo, Mei-Chu and Aulabaugh, Ann and Jin, Guixian and
  Cowling, Rebecca and Bard, Jonathan and Malamas, Michael and Ellestad,
  George}]{Lo:2004gy}
\textbf{\color{eLifeMediumGrey} Lo MC}, Aulabaugh A, Jin G, Cowling R, Bard J,
  Malamas M, Ellestad G.
\newblock {Evaluation of fluorescence-based thermal shift assays for hit
  identification in drug discovery}.
\newblock Analytical Biochemistry.  2004 Sep; 332(1):153--159.

\bibitem[{Ericsson et~al.(2006)Ericsson, Ulrika B and Hallberg, B Martin and
  Detitta, George T and Dekker, Niek and Nordlund, P{\"a}r}]{Ericsson:2006dx}
\textbf{\color{eLifeMediumGrey} Ericsson UB}, Hallberg BM, Detitta GT, Dekker
  N, Nordlund P.
\newblock {Thermofluor-based high-throughput stability optimization of proteins
  for structural studies.}
\newblock Analytical Biochemistry.  2006 Oct; 357(2):289--298.

\bibitem[{Matulis et~al.(2005)Matulis, Daumantas and Kranz, James K and
  Salemme, F Raymond and Todd, Matthew J}]{Matulis:2005dq}
\textbf{\color{eLifeMediumGrey} Matulis D}, Kranz JK, Salemme FR, Todd MJ.
\newblock {Thermodynamic stability of carbonic anhydrase: measurements of
  binding affinity and stoichiometry using ThermoFluor.}
\newblock Biochemistry.  2005 Apr; 44(13):5258--5266.

\bibitem[{Iyer et~al.(2008)Iyer, Ganesh H and Taslimi, Paul and Pazhanisamy,
  S}]{Iyer:2008is}
\textbf{\color{eLifeMediumGrey} Iyer GH}, Taslimi P, Pazhanisamy S.
\newblock {Staurosporine-based binding assay for testing the affinity of
  compounds to protein kinases.}
\newblock Analytical Biochemistry.  2008 Feb; 373(2):197--206.

\bibitem[{Levinson and Boxer(2012)Nicholas M. Levinson and Steven G.
  Boxer}]{levinson-boxer:plos-one:2012:bosutinib}
\textbf{\color{eLifeMediumGrey} Levinson NM}, Boxer SG.
\newblock Structural and Spectroscopic Analysis of the Kinase Inhibitor
  Bosutinib and an Isomer of Bosutinib Binding to the {Abl} Tyrosine Kinase
  Domain.
\newblock PLoS One.  2012; 7:e29828.

\bibitem[{Levinson and Boxer(2014)Levinson, Nicholas M and Boxer, Steven
  G}]{Levinson:2014gi}
\textbf{\color{eLifeMediumGrey} Levinson NM}, Boxer SG.
\newblock {A conserved water-mediated hydrogen bond network defines bosutinib's
  kinase selectivity.}
\newblock Nature chemical biology.  2014 Feb; 10(2):127--132.

\bibitem[{Varghese and Berger(2014)Varghese, Anna M and Berger, Michael
  F}]{Varghese:2014jw}
\textbf{\color{eLifeMediumGrey} Varghese AM}, Berger MF.
\newblock {Advancing clinical oncology through genome biology and technology.}
\newblock Genome biology.  2014 Aug; 15(8):427.

\bibitem[{Zehir et~al.(2017{\natexlab{b}})Zehir, Ahmet and Benayed, Ryma and
  Shah, Ronak H and Syed, Aijazuddin and Middha, Sumit and Kim, Hyunjae R and
  Srinivasan, Preethi and Gao, Jianjiong and Chakravarty, Debyani and Devlin,
  Sean M and Hellmann, Matthew D and Barron, David A and Schram, Alison M and
  Hameed, Meera and Dogan, Snjezana and Ross, Dara S and Hechtman, Jaclyn F and
  DeLair, Deborah F and Yao, JinJuan and Mandelker, Diana L and Cheng, Donavan
  T and Chandramohan, Raghu and Mohanty, Abhinita S and Ptashkin, Ryan N and
  Jayakumaran, Gowtham and Prasad, Meera and Syed, Mustafa H and Rema, Anoop
  Balakrishnan and Liu, Zhen Y and Nafa, Khedoudja and Borsu, Laetitia and
  Sadowska, Justyna and Casanova, Jacklyn and Bacares, Ruben and Kiecka, Iwona
  J and Razumova, Anna and Son, Julie B and Stewart, Lisa and Baldi, Tessara
  and Mullaney, Kerry A and Al-Ahmadie, Hikmat and Vakiani, Efsevia and
  Abeshouse, Adam A and Penson, Alexander V and Jonsson, Philip and Camacho,
  Niedzica and Chang, Matthew T and Won, Helen H and Gross, Benjamin E and
  Kundra, Ritika and Heins, Zachary J and Chen, Hsiao-Wei and Phillips, Sarah
  and Zhang, Hongxin and Wang, Jiaojiao and Ochoa, Angelica and Wills, Jonathan
  and Eubank, Michael and Thomas, Stacy B and Gardos, Stuart M and Reales,
  Dalicia N and Galle, Jesse and Durany, Robert and Cambria, Roy and Abida,
  Wassim and Cercek, Andrea and Feldman, Darren R and Gounder, Mrinal M and
  Hakimi, A Ari and Harding, James J and Iyer, Gopa and Janjigian, Yelena Y and
  Jordan, Emmet J and Kelly, Ciara M and Lowery, Maeve A and Morris, Luc G T
  and Omuro, Antonio M and Raj, Nitya and Razavi, Pedram and Shoushtari,
  Alexander N and Shukla, Neerav and Soumerai, Tara E and Varghese, Anna M and
  Yaeger, Rona and Coleman, Jonathan and Bochner, Bernard and Riely, Gregory J
  and Saltz, Leonard B and Scher, Howard I and Sabbatini, Paul J and Robson,
  Mark E and Klimstra, David S and Taylor, Barry S and Baselga, Jose and
  Schultz, Nikolaus and Hyman, David M and Arcila, Maria E and Solit, David B
  and Ladanyi, Marc and Berger, Michael F}]{Zehir:2017ib}
\textbf{\color{eLifeMediumGrey} Zehir A}, Benayed R, Shah RH, Syed A, Middha S,
  Kim HR, Srinivasan P, Gao J, Chakravarty D, Devlin SM, Hellmann MD, Barron
  DA, Schram AM, Hameed M, Dogan S, Ross DS, Hechtman JF, DeLair DF, Yao J,
  Mandelker DL, et~al.
\newblock {Mutational landscape of metastatic cancer revealed from prospective
  clinical sequencing of 10,000 patients.}
\newblock Nature medicine.  2017 May; 159:676.

\bibitem[{Garraway(2013)Garraway, Levi A}]{Garraway:2013kn}
\textbf{\color{eLifeMediumGrey} Garraway LA}.
\newblock {Genomics-driven oncology: framework for an emerging paradigm.}
\newblock Journal of clinical oncology : official journal of the American
  Society of Clinical Oncology.  2013 May; 31(15):1806--1814.

\bibitem[{Cerami et~al.(2012{\natexlab{b}})Cerami, Ethan and Gao, Jianjiong and
  Dogrusoz, Ugur and Gross, Benjamin E. and Sumer, Selcuk Onur and Aksoy,
  B?lent Arman and Jacobsen, Anders and Byrne, Caitlin J. and Heuer, Michael L.
  and Larsson, Erik and Antipin, Yevgeniy and Reva, Boris and Goldberg, Arthur
  P. and Sander, Chris and Schultz, Nikolaus}]{cBioPortal}
\textbf{\color{eLifeMediumGrey} Cerami E}, Gao J, Dogrusoz U, Gross BE, Sumer
  SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B,
  Goldberg AP, Sander C, Schultz N.
\newblock The {{cBio Cancer Genomics Portal}}: {{An Open Platform}} for
  {{Exploring Multidimensional Cancer Genomics Data}}: {{Figure}} 1.
\newblock Cancer Discovery.  2012 May; 2(5):401--404.
\newblock \href{10.1158/2159-8290.CD-12-0095}{\doiprefix
  \detokenize{10.1158/2159-8290.CD-12-0095}}.

\bibitem[{Cheng et~al.(2015)Cheng, Donavan T. and Mitchell, Talia N. and Zehir,
  Ahmet and Shah, Ronak H. and Benayed, Ryma and Syed, Aijazuddin and
  Chandramohan, Raghu and Liu, Zhen Yu and Won, Helen H. and Scott, Sasinya N.
  and Brannon, A. Rose and O'Reilly, Catherine and Sadowska, Justyna and
  Casanova, Jacklyn and Yannes, Angela and Hechtman, Jaclyn F. and Yao, Jinjuan
  and Song, Wei and Ross, Dara S. and Oultache, Alifya and Dogan, Snjezana and
  Borsu, Laetitia and Hameed, Meera and Nafa, Khedoudja and Arcila, Maria E.
  and Ladanyi, Marc and Berger, Michael F.}]{msk-impact}
\textbf{\color{eLifeMediumGrey} Cheng DT}, Mitchell TN, Zehir A, Shah RH,
  Benayed R, Syed A, Chandramohan R, Liu ZY, Won HH, Scott SN, Brannon AR,
  O'Reilly C, Sadowska J, Casanova J, Yannes A, Hechtman JF, Yao J, Song W,
  Ross DS, Oultache A, et~al.
\newblock Memorial {{Sloan Kettering}}-{{Integrated Mutation Profiling}} of
  {{Actionable Cancer Targets}} ({{MSK}}-{{IMPACT}}).
\newblock The Journal of Molecular Diagnostics.  2015 May; 17(3):251--264.
\newblock \href{10.1016/j.jmoldx.2014.12.006}{\doiprefix
  \detokenize{10.1016/j.jmoldx.2014.12.006}}.

\bibitem[{Reva et~al.(2007)Reva, Boris and Antipin, Yevgeniy and Sander,
  Chris}]{reva_determinants_2007}
\textbf{\color{eLifeMediumGrey} Reva B}, Antipin Y, Sander C.
\newblock Determinants of protein function revealed by combinatorial entropy
  optimization.
\newblock .  2007; 8(11):R232.
\newblock
  \urlprefix\url{http://genomebiology.biomedcentral.com/articles/10.1186/gb-2007-8-11-r232},
  \href{10.1186/gb-2007-8-11-r232}{\doiprefix
  \detokenize{10.1186/gb-2007-8-11-r232}}.

\bibitem[{Reva et~al.(2011)Reva, Boris and Antipin, Yevgeniy and Sander,
  Chris}]{doi:10.1093/nar/gkr407}
\textbf{\color{eLifeMediumGrey} Reva B}, Antipin Y, Sander C.
\newblock Predicting the functional impact of protein mutations: application to
  cancer genomics.
\newblock Nucleic Acids Research.  2011; 39(17):e118.
\newblock \urlprefix\url{http://dx.doi.org/10.1093/nar/gkr407},
  \href{10.1093/nar/gkr407}{\doiprefix \detokenize{10.1093/nar/gkr407}}.

\bibitem[{Ramos et~al.(2015)Ramos, Alex H and Lichtenstein, Lee and Gupta,
  Manaswi and Lawrence, Michael S and Pugh, Trevor J and Saksena, Gordon and
  Meyerson, Matthew and Getz, Gad}]{Ramos:2015ew}
\textbf{\color{eLifeMediumGrey} Ramos AH}, Lichtenstein L, Gupta M, Lawrence
  MS, Pugh TJ, Saksena G, Meyerson M, Getz G.
\newblock {Oncotator: cancer variant annotation tool.}
\newblock Human mutation.  2015 Apr; 36(4):E2423--9.

\bibitem[{Klock et~al.(2008)Klock, Heath E. and Koesema, Eric J. and Knuth,
  Mark W. and Lesley, Scott A.}]{klock_combining_2008}
\textbf{\color{eLifeMediumGrey} Klock HE}, Koesema EJ, Knuth MW, Lesley SA.
\newblock Combining the polymerase incomplete primer extension method for
  cloning and mutagenesis with microscreening to accelerate structural genomics
  efforts.
\newblock Proteins: Structure, Function, and Bioinformatics.  2008 May;
  71(2):982--994.
\newblock \href{10.1002/prot.21786}{\doiprefix
  \detokenize{10.1002/prot.21786}}.

\bibitem[{Velankar et~al.(2013)Velankar, Sameer and Dana, José M. and
  Jacobsen, Julius and van Ginkel, Glen and Gane, Paul J. and Luo, Jie and
  Oldfield, Thomas J. and O’Donovan, Claire and Martin, Maria-Jesus and
  Kleywegt, Gerard J.}]{doi:10.1093/nar/gks1258}
\textbf{\color{eLifeMediumGrey} Velankar S}, Dana JM, Jacobsen J, van Ginkel G,
  Gane PJ, Luo J, Oldfield TJ, O’Donovan C, Martin MJ, Kleywegt GJ.
\newblock SIFTS: Structure Integration with Function, Taxonomy and Sequences
  resource.
\newblock Nucleic Acids Research.  2013; 41(D1):D483.
\newblock \urlprefix\url{http://dx.doi.org/10.1093/nar/gks1258},
  \href{10.1093/nar/gks1258}{\doiprefix \detokenize{10.1093/nar/gks1258}}.

\bibitem[{Sørensen and Mortensen(2005)Hans Peter Sørensen and Kim Kusk
  Mortensen}]{SORENSEN2005113}
\textbf{\color{eLifeMediumGrey} Sørensen HP}, Mortensen KK.
\newblock Advanced genetic strategies for recombinant protein expression in
  Escherichia coli.
\newblock Journal of Biotechnology.  2005; 115(2):113 -- 128.
\newblock
  \urlprefix\url{http://www.sciencedirect.com/science/article/pii/S0168165604004560},
  \href{http://dx.doi.org/10.1016/j.jbiotec.2004.08.004}{\doiprefix
  \detokenize{http://dx.doi.org/10.1016/j.jbiotec.2004.08.004}}.

\bibitem[{Haacke et~al.(2009)Haacke, Annette and Fendrich, Gabriele and Ramage,
  Paul and Geiser, Martin}]{Haacke:ProteinExpr.Purif.:2009}
\textbf{\color{eLifeMediumGrey} Haacke A}, Fendrich G, Ramage P, Geiser M.
\newblock Chaperone Over-Expression in {{Escherichia}} Coli: {{Apparent}}
  Increased Yields of Soluble Recombinant Protein Kinases Are Due Mainly to
  Soluble Aggregates.
\newblock Protein Expr Purif.  2009 Apr; 64(2):185--193.
\newblock \href{10.1016/j.pep.2008.10.022}{\doiprefix
  \detokenize{10.1016/j.pep.2008.10.022}}.

\bibitem[{Kim and Swartz(1999)Kim, Dong-Myung and Swartz, James
  R.}]{Kim:Biotechnol.Bioeng.:1999}
\textbf{\color{eLifeMediumGrey} Kim DM}, Swartz JR.
\newblock Prolonging Cell-Free Protein Synthesis with a Novel {{ATP}}
  Regeneration System.
\newblock Biotechnol Bioeng.  1999; 66(3):180--188.
\newblock
  \href{10.1002/(SICI)1097-0290(1999)66:3<180::AID-BIT6>3.0.CO;2-S}{\doiprefix
  \detokenize{10.1002/(SICI)1097-0290(1999)66:3<180::AID-BIT6>3.0.CO;2-S}}.

\bibitem[{Sawasaki et~al.(2002)Sawasaki, T. and Ogasawara, T. and Morishita, R.
  and Endo, Y.}]{Sawasaki:Proc.Natl.Acad.Sci.:2002a}
\textbf{\color{eLifeMediumGrey} Sawasaki T}, Ogasawara T, Morishita R, Endo Y.
\newblock A Cell-Free Protein Synthesis System for High-Throughput Proteomics.
\newblock Proc Natl Acad Sci.  2002 Nov; 99(23):14652--14657.
\newblock \href{10.1073/pnas.232580399}{\doiprefix
  \detokenize{10.1073/pnas.232580399}}.

\end{thebibliography}
